Advanced search
Publication Cover
Drug Metabolism Reviews Volume 44, 2012 - Issue 1
Submit an article Journal homepage
2,811
Views
212
CrossRef citations to date
0
Altmetric
Review Article

Central role of mitochondria in drug-induced liver injury

Dominique PessayreINSERM, U773, Centre de Recherche Bichat Beaujon CRB3, Faculté de Médecine Xavier-Bichat, Paris, France; Université Paris, Paris, FranceCorrespondence[email protected]
,
Bernard FromentyINSERM, U991, Foie, Métabolismes et Cancer, Rennes, France
,
Alain BersonINSERM, U773, Centre de Recherche Bichat Beaujon CRB3, Faculté de Médecine Xavier-Bichat, Paris, France; Université Paris, Paris, France
,
Marie-Anne RobinINSERM, U991, Foie, Métabolismes et Cancer, Rennes, France
,
Philippe LettéronINSERM, U773, Centre de Recherche Bichat Beaujon CRB3, Faculté de Médecine Xavier-Bichat, Paris, France; Université Paris, Paris, France
,
Richard MoreauINSERM, U773, Centre de Recherche Bichat Beaujon CRB3, Faculté de Médecine Xavier-Bichat, Paris, France; Université Paris, Paris, France
&
Abdellah MansouriINSERM, U773, Centre de Recherche Bichat Beaujon CRB3, Faculté de Médecine Xavier-Bichat, Paris, France; Université Paris, Paris, France
 show all
Pages 34-87 | Received 26 Apr 2011, Accepted 03 Jul 2011, Published online: 30 Jan 2012

References

  • Ackerman, Z., Flugelman, M. Y., Wax, Y., Shouval, D., Levy, M. (1989). Hepatitis during measles in young adults: possible role of antipyretic drugs. Hepatology 10:203–206.
  • Aires, C. C., Ijlst, L., Stet, F., Prip-Buus, C., de Almeida, I. T., Duran, M., et al. (2010). Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis. Biochem Pharmacol 79:792–799.
  • Aithal, GP, Ramsay, L, Daly, AK, Sonchit, N, Leathart, JB, Alexander, G, et al. (2004). Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39:1430–1440.
  • Albrecht, H., Schook, L. B., Jongeneel, C. V. (1995). Nuclear migration of NF-κB correlates with TNF-α mRNA accumulation. J Inflamm 45:64–71.
  • Allemand, H., Pessayre, D., Descatoire, V., DeGott, C., Feldmann, G., Benhamou, J. P. (1978). Metabolic activation of trichloroethylene into a chemically reactive metabolite toxic to the liver. J Pharmacol Exp Ther 204:714–723.
  • Anandatheerthavarada, H. K., Addya, S., Dwivedi, R. S., Biswas, G., Mullick, J., Avadhani, N. G. (1997). Localization of multiple forms of inducible cytochromes P450 in rat liver mitochondria: immunological characteristics and patterns of xenobiotic substrate metabolism. Arch Biochem Biophys 339:136–150.
  • Anandatheerthavarada, H. K., Vijayasarathy, C., Bhagwat, S. V., Biswas, G., Mullick, J., Avadhani, N. G. (1999). Physiological role of the N-terminal processed P4501A1 targeted to mitochondria in erythromycin metabolism and reversal of erythromycin-mediated inhibition of mitochondrial protein synthesis. J Biol Chem 274:6617–6625.
  • Apostolova, N., Gomez-Sucerquia, L. J., Moran, A., Alvarez, A., Blas-Garcia, A., Esplugues, J. V. (2010). Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells. Br J Pharmacol 160:2069–2084.
  • Ariyoshi, N., Iga, Y., Hirata, K., Sato, Y., Miura, G., Ishii, I., et al. (2010). Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese. Drug Metab Pharmacokinet 25:298–306.
  • Arnér, E. S., Holmgren, A. (2000). Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267:6102–6109.
  • Babany, G., Larrey, D., Pessayre, D., Degott, C., Rueff, B., Benhamou, J. P. (1987). Chronic active hepatitis caused by benzarone. J Hepatol 5:332–335.
  • Bae, M. A., Song, B. Y. (2003). Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells. Mol Pharmacol 63:401–408.
  • Bailey, C. M., Kasiviswanathan, R., Copeland, W. C., Anderson, K. S. (2009). R964C mutation of DNA polymerase gamma imparts increased stavudine toxicity by decreasing nucleoside analog discrimination and impairing polymerase activity. Antimicrob Agents Chemother 53:2610–2612.
  • Bajt, M. L., Knight, T. R., Farhood, A., Jaeschke, H. (2003). Scavenging peroxynitrite with glutathione promotes regeneration and enhances survival during acetaminophen-induced liver injury in mice. J Pharmacol Exp Ther 307:67–73.
  • Balakirev, M. Y., Zimmer, G. (2001). Mitochondrial injury by disulfiram: two different mechanisms of the mitochondrial permeability transition. Chem Biol Interact 138:299–311.
  • Banasch, M., Goetze, O., Knyhala, K., Potthoff, A., Schlottmann, R., Kwiatek, M. A., et al. (2006). Uridine supplementation enhances hepatic mitochondrial function in thymidine-analogue treated HIV-infected patients. AIDS 20:1554–1556.
  • Barile, M., Valenti, D., Passarella, S., Quagliariello, E. (1997). 3′-Azido-3′-deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator. Biochem Pharmacol 53:913–920.
  • Bartley, P. B., Westacott, L., Boots, R. J., Lawson, M., Potter, J. M., Hyland, V. J., Woods, M. L. II (2001). Large hepatic mitochondrial DNA deletions associated with L-lactic acidosis and highly active antiretroviral therapy. AIDS 15:419–420.
  • Beaune, P, Dansette, PM, Mansuy, D, Kiffel, L, Finck, M, Amar, C., et al. (1987). Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci U S A 84:551–555.
  • Beaune, P., Pessayre, D., Dansette, P., Mansuy, D., Manns, M. (1994). Autoantibodies against cytochromes P450: role in human diseases. Adv Pharmacol 30:199–245.
  • Bedossa, P., Houglum, K., Trautwein, C., Holstege, A., Chojkier, M. (1994). Stimulation of collagen α-1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 19:1262–1271.
  • Begriche, K., Massart, J., Robin, M. A., Borgne-Sanchez, A., Fromenty, B. (2011). Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 54:773–794.
  • Bellomo, G., Orrenius, S. (1985). Altered thiol and calcium homeostasis in oxidative hepatocellular injury. Hepatology 5:876–882.
  • Belzacq, A. S., El Hamel, C., Vieira, H. L., Cohen, I., Haouzi, D., Métivier, D., et al. (2001). Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite, and CD437. Oncogene 20:7579–7587.
  • Bentley, J. B., Vaughan, R. W., Gandolfi, A. J., Cork, R. C. (1982). Halothane biotransformation in obese and nonobese patients. Anesthesiology 57:94–97.
  • Bergeron, R. J., Neims, A. H., McManis, J. S., Hawthorne, T. R., Vinson, J. R., Bortell, R., et al. (1988). Synthetic polyamine analogues as antineoplastics. J Med Chem 31:1183–1190.
  • Berhane, K., Widersten, M., Engström, A., Kozarich, J. W., Mannervik, B. (1994). Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci U S A 91:1480–1484.
  • Berson, A., Wolf, C., Berger, V., Fau, D., Chachaty, C., Fromenty, B., et al. (1991). Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide. J Pharmacol Exp Ther 257:714–719.
  • Berson, A., Wolf, C., Chachaty, C., Fisch, C., Fau, D., Eugene, D., et al. (1993). Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies. J Pharmacol Exp Ther. 265:366–372.
  • Berson, A., Fréneaux, E., Larrey, D., Lepage, V., Douay, C., Mallet, C., et al. (1994). Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis. J Hepatol 20:336–342.
  • Berson, A., Renault, S., Lettéron, P., Robin, M. A., Fromenty, B., Fau, D., et al. (1996). Uncoupling of rat and human mitochondria: a possible explanation for tacrine-induced liver dysfunction. Gastroenterology 110:1878–1890.
  • Berson, A., De Beco, V., Lettéron, P., Robin, M. A., Moreau, C., El Kahwaji, J., et al. (1998). Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 114:764–774.
  • Berson, A., Descatoire, V., Sutton, A., Fau, D., Maulny, B., Vadrot, N., et al. (2001a). Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem in rat hepatocytes. Role of mitochondrial permeability transition and metabolic activation. J Pharmacol Exp Ther 299:793–800.
  • Berson, A., Fau, D., Fornacciari, R., Degove-Goddard, P., Sutton, A., Descatoire, V., et al. (2001b). Mechanism for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation. J Hepatol 34:261–269.
  • Berson, A., Gervais, A., Cazals, D., Boyer, N., Durand, F., Bernuau, J., et al. (2001c). Hepatitis after buprenorphine misuse in heroin addicts. J Hepatol 34:346–350.
  • Berson, A., Cazanave, S., Descatoire, V., Tinel, M., Grodet, A., Wolf, C., et al. (2006). The anti-inflammatory drug, nimesulide (4-nitro-2-phenoxymethane-sulfoanilide), uncouples mitochondria and induces mitochondrial permeability transition in human hepatoma cells: protection by albumin. J Pharmacol Exp Ther 318:444–454.
  • Bioulac-Sage, P., Parrot-Roulaud, F., Mazat, J. P., Lamireau, T., Coquet, M., Sandler, B., et al. (1993). Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation deficiency): a light and electron microscopic study of the liver. Hepatology 18:839–846.
  • Biour, M., Ben Salem, C., Chazouillères, O., Grangé, J. D., Serfaty, L., Poupon, R. (2004). [Drug-induced liver injury: fourteenth updated edition of the bibliographic database of liver injuries and related drugs]. Gastroenterol Clin Biol 28:720–759.
  • Bitomsky, N., Hofmann, T. G. (2009). Apoptosis and autophagy: regulation of apoptosis by DNA damage signalling—roles of p53, p73, and HIPK2. FEBS J 276:6074–6083.
  • Bjorge, S. M., Baillie, T. A. (1985). Inhibition of medium-chain fatty acid β-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid. Biochem Biophys Res Commun 132:245–252.
  • Black, M., Mitchell, J. R., Zimmerman, H. J., Ishak, K. G., Epler, G. R. (1975). Isoniazid-associated hepatitis in 114 patients. Gastroenterology 69:289–302.
  • Blas-García, A., Apostolova, N., Ballesteros, D., Monleón, D., Morales, J. M., Rocha, M., et al. (2010). Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells. Hepatology 52:115–125.
  • Boehning, D., Patterson, R. L., Sedaghat, L., Glebova, N. O., Kurosaki, T., Snyder, S. H. (2003). Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 5:1051–1061.
  • Borutaité, V., Brown, G. C. (1996). Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide. Biochem J 315:295–299.
  • Bourdi, M., Larrey, D., Nataf, J., Bernuau, J., Pessayre, D., Iwasaki, M., et al. (1990). Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis. J Clin Invest 85:1967–1973.
  • Bourdi, M., Tinel, M., Beaune, P. H., Pessayre, D. (1994). Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies. Mol Pharmacol 45:1287–1295.
  • Bourdi, M., Chen, W., Peter, R. M., Martin, J. L., Buters, J. T., Nelson, S. D., et al. (1996). Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol 9:1159–1166.
  • Boya, P., Andreau, K., Poncet, D., Zamzami, N., Perfettini, J. L., Metivier, D., et al. (2003a). Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 197:1323–1334.
  • Boya, P., Gonzalez-Polo, R. A., Poncet, D., Andreau, K., Vieira, H. L., Roumier, T., et al. (2003b). Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22:3927–3936.
  • Boyd, J. A., Eling, T. E. (1985). Metabolism of aromatic amines by prostaglandin H synthase. Environ Health Perspect 64:45–51.
  • Boyd, M. R., Stiko, A. W., Sasame, H. A. (1979). Metabolic activation of nitrofurantoin–possible implications for carcinogenesis. Biochem Pharmacol 28:601–606.
  • Bravo, J. F., Jacobson, M. P., Mertens, B. F. (1997). Fatty liver and pleural effusion with ibuprofen therapy. Ann Intern Med 87:200–201.
  • Breckenridge, D. G., Germain, M., Mathai, J. P., Nguyen, M., Shore, G. C. (2003). Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22:8608–8618.
  • Breen, K., Wandscheer, J. C., Peignoux, M., Pessayre, D. (1982). In situ formation of the acetaminophen metabolite covalently bound in kidney and lung. Supportive evidence provided by total hepatectomy. Biochem Pharmacol 31:115–116.
  • Brivet, F. G., Nion, I., Mégarbane, B., Slama, A., Brivet, P., Rustin, P., et al. (1999). Fatal lactic acidosis and liver steatosis associated with didanosine and stavudine treatment: a respiratory chain dysfunction? J Hepatol 30:364–365.
  • Bröker, L. E., Huisman, C., Span, S. W., Rodriguez, J. A., Kruyt, F. A. E., Giaccone, G. (2004). Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res 64:27–30.
  • Brown, B. D., Lillicrap, D. (2002). Dangerous liaisons: the role of “danger” signals in the immune response to gene therapy. Blood 100:1133–1140.
  • Brunmair, B., Lest, A., Staniek, K., Gras, F., Scharf, N., Roden, M., et al. (2004). Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I. J Pharmacol Exp Ther 311:109–114.
  • Bruno, S., Maisonneuve, P., Castellana, P., Rotmensz, N., Rossi, S., Maggioni, M., et al. (2005). Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. Br Med J 330:932.
  • Burke, A. S., Redeker, K., Kurten, R. C., James, L. P., Hinson, J. A. (2007). Mechanisms of chloroform-induced hepatotoxicity: oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Toxicol Environ Health A 70:1936–1945.
  • Cai, J., Jones, D. P. (1998). Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 273:11401–11404.
  • Caldwell, S. H., Swerdlow, R. H., Khan, E. M., Iezzoni, J. C., Hespenheide, E. E., Parks, J. K., et al. (1999). Mitochondrial abnormalities in nonalcoholic steatohepatitis. J Hepatol 31:430–434.
  • Caldwell, S. H., Hespenheide, E. E., von Borstel, R. W. (2001). Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin. Dig Dis Sci 46:376–378.
  • Cantó, C., Auwerx, J. (2009). PGC-1alpha, SIRT1, and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 20:98–105.
  • Carey, M. A., van Pelt, F. N. (2005). Immunochemical detection of flucloxacillin adduct formation in livers of treated rats. Toxicology 216:41–48.
  • Carini, R., Bellomo, G., Benedetti, A., Fulceri, R., Gamberucci, A., Parola, M., et al. (1995). Alteration of Na+ homeostasis as a critical step in the development of irreversible hepatocyte injury after adenosine triphosphate depletion. Hepatology 21:1089–1098.
  • Carini, R., Autelli, R., Bellomo, G., Albano, E. (1999). Alterations of cell volume regulation in the development of hepatocyte necrosis. Exp Cell Res 248:280–299.
  • Caron-Debarle, M., Lagathu, C., Boccara, F., Vigouroux, C., Capeau, J. (2010). HIV-associated lipodystrophy: from fat injury to premature aging. Trends Mol Med 16:218–229.
  • Carr, D. F., Alfirevic, A., Tugwood, J. D., Barratt, B. J., Sherwood, J., Smith, J., et al. (2007). Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity. Pharmacogenet Genomics 17:961–972.
  • Carvalho, M., Milhazes, N., Remião, F., Borges, F., Fernandes, E., Amado, F., et al. (2004). Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch Toxicol 78:16–24.
  • Castéra, L., Kalinsky, E., Bedossa, P., Tertian, G., Buffet, C. (1999). Macrovacuolar steatosis induced by interferon alfa therapy for chronic myelogenous leukemia. Liver 19:259–260.
  • Castrejon, J. L., Lavergne, S. N., El-Sheikh, A., Farrell, J., Maggs, J. L., Sabbani, S., et al. (2010). Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives. Chem Res Toxicol 23:184–192.
  • Castro, J., Ruminot, I., Porras, O. H., Flores, C. M., Hermosilla, T., Verdugo, E., et al. (2006). ATP steal between cation pumps: a mechanism linking Na+ influx to the onset of necrotic Ca2+ overload. Cell Death Differ 13:1675–1685.
  • Catisti, R., Vercesi, A. (1999). The participation of pyridine nucleotides redox state and reactive oxygen in the fatty acid-induced permeability transition in rat liver mitochondria. FEBS Lett 464:97–101.
  • Chabrol, B., Mancini, J., Chretien, D., Rustin, P., Munnich, A., Pinsard, N. (1994). Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency. Eur J Pediatr 153:133–135.
  • Chaggar, P. S., Shaw, S. M., Williams, S. G. (2011). Effect of antipsychotic medications on glucose and lipid levels. J Clin Pharmacol 51:631–638.
  • Chalasani, N. (2005). Statins and hepatotoxicity: focus on patients with fatty liver. Hepatology 41:690–695.
  • Chariot, P., Drogou, I., de Lacroix-Szmania, I., Eliezer-Vanerot, M. C., Chazaud, B., Lombès, A., et al. (2000). Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J Hepatol 32:364–365.
  • Chen, C. H., Cheng, Y. C. (1989). Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. J Biol Chem 264:11934–11937.
  • Chen, Q., Ngui, J. S., Doss, G. A., Wang, R. W., Cai, X., DiNinno, F. P., et al. (2002). Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation. Chem Res Toxicol 15:907–914.
  • Chipuk, J. E., Fisher, J. C., Dillon, C. P., Kriwacki, R. W., Kuwana, T, Green, D. R. (2008). Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci U S A 105:20327–20332.
  • Chow, E. K., Castrillo, A., Shahangian, A., Pei, L., O′Connell, R. M., Modlin, R. L., et al. (2006). A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections. J Exp Med 203:2589–2602.
  • Christ, D. D., Kenna, J. G., Kammerer, W., Satoh, H., Pohl, L. R. (1988a). Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis. Anesthesiology 69:833–838.
  • Christ, D. D., Satoh, H., Kenna, J. G., Pohl, L. R. (1988b). Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane. Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane. Drug Metab Dispos 16:135–140.
  • Chrzanowska-Lightowlers, Z. M., Preiss, T., Lightowlers, R. N. (1994). Inhibition of mitochondrial protein synthesis promotes increased stability of nuclear-encoded respiratory gene transcripts. J Biol Chem 269:27322–27328.
  • Clarke, L., Waxman, D. J. (1989). Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation. Cancer Res 49:2344–2350.
  • Cocco, T., Cutecchia, G., Montedoro, G., Lorusso, M. (2002). The antihypertensive drug carvedilol inhibits the activity of mitochondrial NADH-ubiquinone oxidoreductase. J Bioenerg Biomembr 34:251–258.
  • Coles, B. (1985). Effects of modifying structure on electrophilic reactions with biological nucleophiles. Drug Metab Rev 15:1307–1334.
  • Cortez-Pinto, H., Baptista, A., Camilo, M. A., de Costa, E. B., Valente, A., de Moura, M. C. (1995). Tamoxifen-associated steatohepatitis—report of three cases. J Hepatol 23: 95–97.
  • Cortez-Pinto, H., Chatham, J., Chacko, V. P., Arnold, C., Rashid, A., Diehl, A. M. (1999). Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis. A pilot study. JAMA 282:1659–1664.
  • Costantini, P., Chernyak, B. V., Petronilli, V., Bernardi, P. (1996). Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem 271:6746–6751.
  • Cover, C., Mansouri, A., Knight, T. R., Bajt, M. L., Lemasters, J. J., Pessayre, D., et al. (2005). Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity. J Pharmacol Exp Ther 315:879–887.
  • Cox, A. G., Winterbourn, C. C., Hampton, M. B. (2010). Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J 425:313–325.
  • Cribb, A. E., Lee, B. L., Trepanier, L. A., Spielberg, S. P. (1996). Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev 15:9–50.
  • Curzio, M., Esterbauer, H., Dianzani, M. U. (1985). Chemotactic activity of hydroxyalkenals on rat neutrophils. Int J Tissue React 7:137–142.
  • Dahl, M. G., Gregory, M. M., Scheuer, P. J. (1972). Methotrexate hepatotoxicity in psoriasis—comparison of different dose regimens. Br Med J 1:654–656.
  • Dai, Y., Rashba-Step, J., Cederbaum, A. I. (1993). Stable expression of human cytochrome P450 2E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry 32:6928–6937.
  • Daly, A. K., Donaldson, P. T., Bhatnagar, P., Shen, Y., Pe′er, I, Floratos, A., et al.; DILIGEN Study; International SAE Consortium. (2009). HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 41:816–819.
  • Danan, G., Descatoire, V., Pessayre, D. (1981). Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. J Pharmacol Exp Ther 218:509–514.
  • Danan, G., Trunet, P., Bernuau, J., Degott, C., Babany, G., Pessayre, D., et al. (1985). Pirprofen-induced fulminant hepatitis. Gastroenterology 89:210–213.
  • Dansette, P. M., Libraire, J., Bertho, G., Mansuy, D. (2009). Metabolic oxidative cleavage of thioesters: evidence for the formation of sulfenic acid intermediates in the bioactivation of the antithrombotic prodrugs ticlopidine and clopidogrel. Chem Res Toxicol 22:369–373.
  • Davies, H. W., Britt, S. G., Pohl, L. R. (1986). Carbon tetrachloride and 2-isopropyl-4-pentenamide-induced inactivation of cytochrome P-450 leads to heme-derived protein adducts. Arch Biochem Biophys 244:387–392.
  • de Baar, M. P., de Rooij, E. R., Smolders, K. G., van Schijndel, H. B., Timmermans, E. C., Bethell, R. (2007). Effects of apricitabine and other nucleoside reverse transcriptase inhibitors on replication of mitochondrial DNA in HepG2 cells. Antiviral Res 76:68–74.
  • De Berardinis, V., Moulis, C., Maurice, M., Beaune, P., Pessayre, D., Pompon, D., et al. (2000). Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 58:542–551.
  • De Bus, L., Depuydt, P., Libbrecht, L., Vandekerckhove, L., Nollet, J., Benoit, D., et al. (2010). Severe drug-induced liver injury associated with prolonged use of linezolid. J Med Toxicol 6:322–326.
  • Degoul, F., Sutton, A., Mansouri, A., Cepanec, C., Degott, C., Fromenty, B., et al. (2001). Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 120:1468–1474.
  • de la Asuncion, J. G., del Olmo, M. L., Sastre, J., Millan, A., Pellin, A., Pallardo, F. V. (1998). AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. J Clin Invest 102:4–9.
  • de la Asuncion, J. G., del Olmo, M. L., Sastre, J., Pallardo, F. V., Vina, J. (1999). Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver. Hepatology 29:985–987.
  • De la Iglesia, F. A., Feuer, G., Takada, A., Matsuda, Y. (1974). Morphologic studies on secondary phospholipidosis in humans. Lab Invest 4:539–549.
  • Demeilliers, C., Maisonneuve, C., Grodet, A., Mansouri, A., Nguyen, R., Tinel, M., et al. (2002). Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology 123:1278–1290.
  • Deng, X, Stachlewitz, R. F., Liguori, M. J., Blomme, E. A., Waring, J. F., Luyendyk, J. P., et al. (2006). Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation. J Pharmacol Exp Ther 319:1191–1199.
  • Deniaud, A., Sharaf el dein, O., Maillier, E., Poncet, D., Kroemer, G., Lemaire, C., et al. (2008). Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization, and apoptosis. Oncogene 27:285–299.
  • Derks, T. G. J., van Dijk, T. H., Grefhorst, A., Rake, J. P., Smit, G. P. A., Kuipers, F., et al. (2008). Inhibition of mitochondrial fatty acid oxidation in vivo only slightly suppresses gluconeogenesis but enhances clearance of glucose in mice. Hepatology 47:1032–1042
  • Desagher, S., Osen-Sand, A., Nichols, A., Eskes, R., Montessuit, S., Lauper, S., et al. (1999). Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144:891–901.
  • Deschamps, D., Fisch, C., Fromenty, B., Berson, A., Degott, C., Pessayre, D. (1991). Inhibition by salicylic acid of the activation and thus oxidation of long-chain fatty acids. Possible role in the development of Reye′s syndrome. J Pharmacol Exp Ther 259:894–904.
  • Deschamps, D., De Beco, V., Fisch, C., Fromenty, B., Guillouzo, A., Pessayre, D. (1994). Inhibition by perhexiline of oxidative phosphorylation and the ß-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions. Hepatology 19:948–961.
  • De Vriese, A. S., Coster, R. V., Smet, J., Seneca, S., Lovering, A., Van Haute, L. L., et al. (2006). Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 42:1111–1117.
  • DHHS. (2009). Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. December 1, 2009; 1–161. Department of Health and Human Services. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
  • Dieckhaus, C. M., Thompson, C. D., Roller, S. G., Macdonald, T. L. (2002). Mechanisms of idiosyncratic drug reactions: the case of felbamate. Chem Biol Interact 142:99–117.
  • DiMauro, S., Schon, E. A. (1998). Nuclear power and mitochondrial disease. Nature Genet 19:214–215.
  • Dinkova-Kostova, A. T., Holtzclaw, W. D., Kensler, T. W. (2005a). The role of Keap1 in cellular protective responses. Chem Res Toxicol 18:1779–1791.
  • Dinkova-Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., et al. (2005b). Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci U S A 102:4584–4589.
  • Dobiás, L., Cerná, M., Rössner, P., Srám, R. (1994). Genotoxicity and carcinogenicity of metronidazole. Mutat Res 317:177–194.
  • Dong, J. Q., Etheridge, A. S., Smith, P. C. (1999). Effect of selective phase II enzyme inducers on glucuronidation of benoxaprofen in rats. Drug Metab Dispos 27:1423–1428.
  • Dong, J. Q., Liu, J., Smith, P. C. (2005). Role of benoxaprofen and flunoxaprofen acyl glucuronides in covalent binding to rat plasma and liver proteins in vivo. Biochem Pharmacol 70:937–948.
  • Dragomir, A. C., Laskin, J. D., Laskin, D. L. (2011). Macrophage activation by factors released from acetaminophen-injured hepatocytes: potential role of HMGB1. Toxicol Appl Pharmacol 253:170–177.
  • Dubois, N., Lapicque, F., Maurice, M. H., Pritchard, M., Fournel-Gigleux, S., Magdalou, J., et al. (1993). In vitro irreversible binding of ketoprofen glucuronide to plasma proteins. Drug Metab Dispos 2:617–623.
  • Dutertre, J. P., Bastides, F., Jonville, A. P., De Muret, A., Sonneville, A., Larrey, D., et al. (1991). Microvesicular steatosis after ketoprofen administration. Eur J Gastroenterol Hepatol 3:953–954.
  • Dybing, E., Nelson, S. D., Mitchell, J. R., Sasame, H. A., Gillette, J. R. (1976). Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis. Mol Pharmacol 12:911–920.
  • Dykens, J. A., Jamieson, J., Marroquin, L., Nadanaciva, S., Billis, P. A., Will, Y. (2008a). Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Toxicol Appl Pharmacol 233:203–210.
  • Dykens, J. A., Jamieson, J. D., Marroquin, L. D., Nadanaciva, S., Xu, J. J., Dunn, M. C., et al. (2008b). In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. Toxicol Sci 103:335–245.
  • Ebert, E. C., Sun, E. A., Wright, S. H., Decker, J. P., Librizzi, R. J., Bolognese, R. J., et al. (1984). Does early diagnosis and delivery in acute fatty liver of pregnancy lead to improvement in maternal and infant survival? Dig Dis Sci 29:453–455.
  • Echiburú, B., Pérez-Bravo, F., Maliqueo, M., Sánchez, F., Crisosto, N., Sir-Petermann, T. (2008). Polymorphism T → C (–34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study. Metabolism 57:1765–1771.
  • Eliasson, E., Kenna, J. G. (1996). Cytochrome P4502E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 50:573–582.
  • El-Serag, H. B., Everhart, J. E. (2002). Diabetes increases the risk of acute hepatic failure. Gastroenterology 122:1822–1828.
  • El-Serag, H. B., Tran, T., Everhart, J. E. (2004). Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126:460–468.
  • Elsheikh, A., Lavergne, S. N., Castrejon, J. L., Farrell, J., Wang, H., Sathish, J., et al. (2010). Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism. J Immunol 185:6448–6460.
  • Emery, M. G., Fisher, J. M., Chien, J. Y., Kharasch, E. D., Dellinger, E. P., Kowdley, KV., et al. (2003). CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology 38:428–435.
  • Epe, B., Ballmaier, D., Roussyn, I., Briviba, K., Sies, H. (1996). DNA damage by peroxynitrite characterized with DNA repair enzymes. Nucleic Acids Res 24:4105–4110.
  • Erster, S., Mihara, M., Kim, R. H., Petrenko, O., Moll, U. M. (2004). In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 24:6728–6741.
  • Esnault, C., Brown, S. C., Segal-Bendirdjian, E., Coulaud, D., Mishal, Z., Roques, B. P., et al. (1990). Selective alteration of mitochondrial function by dirtercalinium (NSC 335153), a DNA bisintercalating agent. Biochem Pharmacol 39:109–122.
  • Esposito, L. A., Melov, S., Panov, A., Cottrell, B. A., Wallace, D. C. (1999). Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci U S A 96:4820–4825.
  • Esterbauer, H., Schaur, R. J., Zollner, H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81–128.
  • Fagian, M. M., Pereira-da-Silva, L., Martins, I. S., Vercesi, A. E. (1990). Membrane protein thiol cross-linking associated with the permeabilization of the inner mitochondrial membrane by Ca2+ plus prooxidants. Biol Chem 265:19955–19960.
  • Farrell, G. (1994). Drug-induced liver disease. London: Churchill-Livingstone.
  • Farrell, G., Prendergast, D., Murray, M. (1985). Halothane hepatitis. Detection of a constitutional susceptibility factor. N Engl J Med 313:1310–1314.
  • Fau, D., Lekehal, M., Farrell, G., Moreau, A., Moulis, C., Feldmann, G., et al. (1997). Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 113:1334–1346.
  • Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., Henderson, B. E. (1997). A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57:1063–1065.
  • Feigelson, H. S., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F. Z., Henderson, B. E. (1998). Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 58:585–587.
  • Feldmann, G., Haouzi, D., Moreau, A., Durand-Schneider, A. M., Bringuier, A., Berson, A., et al. (2000). Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice. Hepatology 31:674–683.
  • Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., et al. (2003). Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125:437–443.
  • Fernandez-Checa, J. C., Garcia-Ruiz, C., Ookhtens, M., Kaplowitz, N. (1991). Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. J Clin Invest 87:397–405.
  • Fernø, J., Vik-Mo, A. O., Jassim, G., Håvik, B., Berge, K., Skrede, S., et al. (2009). Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology (Berl) 203:73–84.
  • Finsterer, J., Segall, L. (2010). Drugs interfering with mitochondrial disorders. Drug Chem Toxicol 33:138–151.
  • Fletcher, J. I., Meusburger, S., Hawkins, C. J., Riglar, D. T., Lee, E. F., Fairlie, W. D., et al. (2008). Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax. Proc Natl Acad Sci U S A 105:18081–18087.
  • Forsyth, B. W., Horwitz, R. I., Acampora, D., Shapiro, E. D., Viscoli, C. M., Feinstein, A. R., et al. (1989). New epidemiologic evidence confirming that bias does not explain the aspirin/Reye′s syndrome association. JAMA 261:2517–2524.
  • Frei, B. (1994). Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med 97:S5–S13
  • Fréneaux, E., Labbe, G., Lettéron, P., Le Dinh, T., Degott, C., Genève, J., et al. (1988). Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology 8:1056–1062.
  • Fréneaux, E., Fromenty, B., Berson, A., Labbe, G., Degott, C., Lettéron, P., et al. (1990). Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial β-oxidation of fatty acids. J Pharmacol Exp Ther 255:529–535.
  • Fridman, J. S., Lowe, S. W. (2003). Control of apoptosis by p53. Oncogene 22:9030–9040.
  • Fromenty, B., Pessayre, D. (1995). Inhibition of mitochondrial β-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 67:101–154.
  • Fromenty, B., Fréneaux, E., Labbe, G., Deschamps, D., Larrey, D., Lettéron, D., et al. (1989). Tianeptine, a new tricyclic antidepressant metabolized by β-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice. Biochem Pharmacol 38:3743–3751.
  • Fromenty, B., Fisch, C., Labbe, G., Degott, C., Deschamps, D., Berson, A., et al. (1990a). Amiodarone inhibits the mitochondrial β-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 255:1371–1376.
  • Fromenty, B., Fisch, C., Berson, A., Lettéron, P., Larrey, D., Pessayre, D. (1990b). Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther 255:1377–1384.
  • Fromenty, B., Lettéron, P., Fisch, C., Berson, A., Deschamps, D., Pessayre, D. (1993). Evaluation of human blood lymphocytes as a model to study the effects of drugs on human mitochondria. Effects of low concentrations of amiodarone on fatty acid oxidation, ATP levels, and cell survival. Biochem Pharmacol 46:421–432.
  • Fromenty, B., Grimbert, S., Mansouri, A., Beaugrand, M., Erlinger, S., Rötig, A., et al. (1995). Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology 108:193–200.
  • Fromenty, B., Mansouri, A., Bonnefont, J. P., Courtois, F., Munnich, A., Rabier, D., et al. (1996). Most cases of medium-chain acyl-CoA dehydrogenase deficiency escape detection in France. Hum Genet 97:367–368.
  • Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., et al. (1998). Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 273:33942–33948.
  • Fulgencio, J. P., Kohl, C., Girard, J., Pégorier, J. P. (1996). Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats. Diabetes 45:1556–1562.
  • Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., et al. (1995). Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223–1230.
  • Gallucci, S., Lolkema, M., Matzinger, P. (1999). Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5:1249–1255.
  • Gandhi, A., Guo, T., Ghose, R. (2010). Role of c-Jun N-terminal kinase (JNK) in regulating tumor necrosis factor-alpha (TNF-alpha) mediated increase of acetaminophen (APAP) and chlorpromazine (CPZ) toxicity in murine hepatocytes. J Toxicol Sci 35:163–173.
  • Garrabou, G., López, S., Morén, C., Martínez, E., Fontdevila, J., Cardellach, F., et al. (2011). Mitochondrial damage in adipose tissue of untreated HIV-infected patients. AIDS 25:165–170.
  • Genève, J., Hayat-Bonan, B., Labbe, G., Degott, C., Lettéron, P., Fréneaux, E., et al. (1987a). Inhibition of mitochondrial β-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug. J Pharmacol Exp Ther 242:1133–1137.
  • Genève, J., Larrey, D., Lettéron, P., Descatoire, V., Tinel, M., Amouyal, G., et al. (1987b). Metabolic activation of the tricyclic antidepressant amineptine. I. Cytochrome P-450-mediated in vitro covalent binding. Biochem Pharmacol 36:323–329.
  • Germain, R. N. (1994). MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287–299.
  • Ginsburg, H., Geary, T. G. (1987). Current concepts and new ideas on the mechanism of action of quinoline-containing antimalarials. Biochem Pharmacol 36:1567–1576.
  • Goebel, C., Vogel, C., Wulferink, M., Mittmann, S., Sachs, B., Schraa, S., et al. (1999). Procainamide, a drug causing lupus, induces prostaglandin H synthase-2 and formation of T cell-sensitizing drug metabolites in mouse macrophages. Chem Res Toxicol 12:488–500.
  • Gombar, C. T., Tong, W. P., Ludlum, D. B. (1980). Mechanism of action of the nitrosoureas—IV. Reactions of bis-chloroethyl nitrosourea and chloroethyl cyclohexyl nitrosourea with deoxyribonucleic acid. Biochem Pharmacol 29:2639–2643.
  • Gori, T., Daiber, A., Di Stolfo, G., Sicuro, S., Dragoni, S., Lisi, M., et al. (2007). Nitroglycerine causes mitochondrial reactive oxygen species production: in vitro mechanistic insights. Can J Cardiol 23:990–992.
  • Graham, E. E., Walsh, R. J., Hirst, C. M., Maggs, J. L., Martin, S., Wild, M. J., et al. (2008). Identification of the thiophene ring of methapyrilene as a novel bioactivation-dependent hepatic toxicophore. J Pharmacol Exp Ther 326:657–671.
  • Grimbert, S., Fromenty, B., Fisch, C., Lettéron, P., Berson, A., Durand-Schneider, A. M., et al. (1993). Decreased mitochondrial oxidation of fatty acids in pregnant mice: possible relevance to development of acute fatty liver of pregnancy. Hepatology 17:628–637.
  • Grimbert, S., Fisch, C., Deschamps, D., Berson, A., Fromenty, B., Feldmann, G., et al. (1995). Effects of female sex hormones on liver mitochondria in non-pregnant female mice: possible role in acute fatty liver of pregnancy. Am J Physiol 268(Gastrointest Liver Physiol):G107–G115.
  • Grislain, L., Gelé, P., Bertrand, M., Luijten, W., Bromet, N., Salvadori, C., et al. (1990). The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers. Drug Metab Dispos 18:804–808.
  • Grunnet, N., Kondrup, J. (1986). The effect of ethanol on the ß-oxidation of fatty acids. Alcohol Clin Exp Res 10:S64–S68
  • Guan, X., Davis, M. R., Tang, C., Jochheim, C. M., Jin, L., Baillie, T. A. (1999). Identification of S-(n-butylcarbamoyl)glutathione, a reactive carbamoylating metabolite of tolbutamide in the rat, and evaluation of its inhibitory effects on glutathione reductase in vitro. Chem Res Toxicol 12:1138–1143.
  • Guengerich, F. P., Liebler, D. C. (1985). Enzymatic activation of chemicals to toxic metabolites. Crit Rev Toxicol 14:259–307.
  • Guigui, B., Perrot, S., Berry, J. P., Fleury-Feith, J., Martin, N., Métreau, J. M., et al. (1988). Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease. Hepatology 8:1063–1068.
  • Gunawan, B. K., Liu, Z. X., Han, D., Hanawa, N., Gaarde, W. A., Kaplowitz, N. (2006). c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 131:165–178.
  • Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., et al. (2007). Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 120:1326–1333.
  • Hägg, M., Berndtsson, M., Mandic, A., Zhou, R., Shoshan, M. C., Linder, S. (2004). Induction of endoplasmic reticulum stress by ellipticine plant alkaloids. Mol Cancer Ther 3:489–497.
  • Halpert, J., Näslund, B., Betnér, I. (1983). Suicide inactivation of rat liver cytochrome P-450 by chloramphenicol in vivo and in vitro Mol Pharmacol 1983;23:445–452.
  • Han, J., Goldstein, L. A., Gastman, B. R., Froelich, C. J., Yin, X. M., Rabinowich, H. (2004). Degradation of Mcl-1 by granzyme B: implications for Bim-mediated mitochondrial apoptotic events. J Biol Chem 279:22020–22029.
  • Hanawa, N., Shinohara, M., Saberi, B., Gaarde, W. A., Han, D., Kaplowitz, N. (2008). Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 283:13565–13577.
  • Haouzi, D., Lekéhal, M., Moreau, A., Moulis, C., Feldmann, G., Robin, M. A., et al. (2000). Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes. Hepatology 32:303–311.
  • Harrill, A. H., Watkins, P. B., Su, S., Ross, P. K., Harbourt, D. E., Stylianou, I. M., et al. (2009). Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Res 19:1507–1515.
  • Hautekeete, M. L., Horsmans, Y., Van Waeyenberge, C., Demanet, C., Henrion, J., Verbist, L., et al. (1999). HLA association of amoxicillin-clavulanate-induced hepatitis. Gastroenterology 117:1181–1186.
  • Heibein, J. A., Goping, I. S., Barry, M., Pinkoski, M. J., Shore, G. C., Green, D. R., et al. (2000). Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax. J Exp Med 192:1391–1402.
  • Herraiz, M., Beraza, N., Solano, A., Sangro, B., Montoya, J., Qian, C., et al. (2003). Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion. Hum Gene Ther 14:463–472.
  • Hirata, K., Takagi, H., Yamamoto, M., Matsumoto, T., Nishiya, T., Mori, K., et al. (2008). Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study. Pharmacogenomics J 8:29–33.
  • Hostetler, K. Y., Reasor, M., Yazaki, P. J. (1985). Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes. J Biol Chem 260:215–219.
  • Hruszkewycz, A. M. (1988). Evidence for mitochondrial DNA damage by lipid peroxidation. Biochem Biophys Res Commun 153:191–197.
  • Hu, B., French, S. W. (1997). 2′,3′-Dideoxyinosine-induced Mallory bodies in patients with HIV. Am J Clin Pathol 108:280–283.
  • Huang, Y. S., Chern, H. D., Su, W. J., Wu, J. C., Lai, S. L., Yang, S. Y., et al. (2002). Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology 35:883–889.
  • Huang, Y. S., Chern, H. D., Su, W. J., Wu, J. C., Chang, S. C., Chiang, C. H., et al. (2003). Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology 37:924–930.
  • Huang, Y. S., Su, W. J., Huang, Y. H., Chen, C. Y., Chang, F. Y., Lin, H. C., et al. (2007). Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H: quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury. J Hepatol 47:128–134.
  • Hug, H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., et al. (1997). Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 272:28191–28193.
  • Hurwitz, E. S., Barrett, M. J., Bregman, D., Gunn, W. J., Schonberger, L. B., Fairweather, W. R., et al. (1985). Public health service study on Reye′s syndrome and medications. Report of the pilot phase. N Engl J Med 313:849–857.
  • Ibdah, J. A., Bennet, M. J., Rinaldo, P., Zhao, Y., Gibson, B., Sims, H. F., et al. (1999). A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. New Engl J Med 340:1723–1731.
  • Inagaki, H., Matsushima, Y., Ohshima, M., Kitagawa, Y. (1997). Interferons suppress mitochondrial gene transcription by depleting mitochondrial transcription factor A (mtTFA). J Interferon Cytokine Res 17:263–269.
  • Ingiliz, P., Valantin, M. A., Duvivier, C., Medja, F., Dominguez, S., Charlotte, F., et al. (2009). Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy. Hepatology 49:436–442.
  • Ishizuka, M., Yoshino, S., Yamamoto, Y., Yamamoto, H., Imaoka, S., Funae, Y., et al. (1997). Isozyme selective alterations of the expression of cytochrome P450 during regeneration of male rat liver following partial hepatectomy. Xenobiotica 27:923–931.
  • Itoh, S., Igarashi, M., Tsukada, Y., Ichinoe, A. (1977). Non-alcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy. Acta Hepato-Gastroenterol 24:415–418.
  • Iverson, S. L., Uetrecht, J. P. (2001). Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity. Chem Res Toxicol 14:175–181.
  • Iwamura, A., Fukami, T., Hosomi, H., Nakajima, M., Yokoi, T. (2011). CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay. Drug Metab Dispos 39:838–846.
  • Jacqz, E., Hall, S. D., Branch, R. A. (1986). Genetically determined polymorphisms in drug oxidation. Hepatology 6:1020–1032.
  • Jamieson, J. D., Smith, E. B., Dalvie, D. K., Stevens, G. J., Yanochko, G. M. (2011). Myeloperoxidase-mediated bioactivation of 5-hydroxythiabendazole: a possible mechanism of thiabendazole toxicity. Toxicol In Vitro 25:1061–1066.
  • Jedlitschky, G., Hoffmann, U., Kroemer, H. K. (2006). Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert Opin Drug Metab Toxicol 2:351–366.
  • Jewell, H., Maggs, J. L., Harrison, A. C., O′Neill, P. M., Ruscoe, J. E., Park, B. K. (1995). Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine. Xenobiotica 25:199–217.
  • Ji, C., Mehrian-Shai, R., Chan, C., Hsu, Y. H., Kaplowitz, N. (2005). Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcohol Clin Exp Res 29:1486–1503.
  • Johnson, A. A., Ray, A. S., Hanes, J., Suo, Z, Colacino, J. M., Anderson, K. S., Johnson, K. A. (2001). Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J Biol Chem 276:40847–40857.
  • Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., Brodie, B. B. (1973). Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther 187:195–202.
  • Joshi, E. M., Heasley, B. H., Macdonald, T. L. (2009). 2-ABT-S-oxide detoxification by glutathione S-transferases A1-1, M1-1 and P1-1: implications for toxicity associated with zileuton. Xenobiotica 39:197–204.
  • Julie, N. L., Julie, I. M., Kende, A. I., Wilson, G. L. (2008). Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone. Diabetologia 51:2108–2116.
  • Kale, V. M., Hsiao, C. J., Boelsterli, U. A. (2010). Nimesulide-induced electrophile stress activates Nrf2 in human hepatocytes and mice but is not sufficient to induce hepatotoxicity in Nrf2-deficient mice. Chem Res Toxicol 23:967–976.
  • Kalgutkar, A. S., Taylor, T. J., Venkatakrishnan, K., Isin, E. M. (2003). Assessment of the contributions of CYP3A4 and CYP3A5 in the metabolism of the antipsychotic agent haloperidol to its potentially neurotoxic pyridinium metabolite and effect of antidepressants on the bioactivation pathway. Drug Metab Dispos 31:243–249.
  • Kalgutkar, A. S., Henne, K. R., Lame, M. E., Vaz, A. D., Collin, C., Soglia, J. R., et al. (2005a). Metabolic activation of the nontricyclic antidepressant trazodone to electrophilic quinone-imine and epoxide intermediates in human liver microsomes and recombinant P4503A4. Chem Biol Interact 155:10–20.
  • Kalgutkar, AS, Vaz, AD, Lame, ME, Henne, KR, Soglia, J, Zhao, SX, et al. (2005b). Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4. Drug Metab Dispos 33:243–253.
  • Kamal, M. A., French, S. W. (2004). Drug-induced mitochondrial biogenesis in a liver biopsy. Exp Mol Pathol 77:201–204.
  • Kang, P., Dalvie, D., Smith, E., Renner, M. (2009). Bioactivation of lumiracoxib by peroxidases and human liver microsomes: identification of multiple quinone imine intermediates and GSH adducts. Chem Res Toxicol 22:106–117.
  • Kaplan, M. M. (1985). Acute fatty liver of pregnancy. N Engl J Med 313:367–370.
  • Kappus, H., Remmer, H. (1975). Irreversible protein binding of [14-C]imipramine with rat and human liver microsomes. Biochem Pharmacol 24:1079–1084.
  • Karbowski, M., Kurono, C., Wozniak, M., Ostrowski, M., Teranishi, M., Nishizawa, Y., et al. (1999). Free radical-induced megamitochondria formation and apoptosis. Free Radic Biol Med 26:396–409.
  • Kashimshetty, R., Desai, V. G., Kale, V. M., Lee, T., Moland, C. L., Branham, W. S., et al. (2009). Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity. Toxicol Appl Pharmacol 238:150–159.
  • Kassahun, K., Farrell, K., Abbott, F. (1991). Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans. Drug Metab Dispos 19:525–535.
  • Kassahun, K., Hu, P., Grillo, M. P., Davis, M. R., Jin, L., Baillie, T. A. (1994). Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent mechanisms. Chem Biol Interact 90:253–275.
  • Kassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., et al. (2001). Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chem Res Toxicol 14:62–70.
  • Katewa, S. D., Katyare, S. S. (2004). Treatment with antimalarials adversely affects the oxidative energy metabolism in rat liver mitochondria. Drug Chem Toxicol 27:41–53.
  • Kaufmann, P., Torok, M., Hanni, A., Roberts, P., Gasser, R., Krähenbühl, S. (2005). Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. Hepatology 41:925–935.
  • Kelly, D. P., Whelan, A. J., Ogden, M. L., Alpers, R., Zhang, Z., Bellus, G., et al. (1990). Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency. Proc Natl Acad Sci U S A 87:9236–9240.
  • Kenna, J. G., Satoh, H., Christ, D. D., Pohl, L. R. (1988). Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J Pharmacol ExpTher 245:1103–1109.
  • Kenne, K., Skanberg, I., Glinghammar, B., Berson, A., Pessayre, D., Flinois, J. P., et al. (2008). Prediction of drug-induced liver injury in human by using in vitro methods: the case of ximelagatran. Toxicol in Vitro 22:730–746.
  • Kent, P. D., Luthra, H. S., Michet, C. Jr (2004). Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis. J Rheumatol 31:1727–1731.
  • Killenberg, P. G., Davidson, E. D., Webster, L. T. (1971). Evidence for a medium-chain fatty acid coenzyme A ligase (adenosine monophosphate) that activates salicylate. Mol Pharmacol 7:260–268.
  • Kindmark, A., Jawaid, A., Harbron, C. G., Barratt, B. J., Bengtsson, O. F., Andersson, T. B., et al. (2008). Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J 8:186–195.
  • Knockaert, L., Descatoire, V., Vadrot, N., Fromenty, B., Robin, M. A. (2011). Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen. Toxicol In Vitro 25:475–484.
  • Kodavanti, U. P., Mehendale, H. M. (1990). Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev 42:327–354.
  • Korenaga, M., Wang, T., Li, Y., Showalter, L. A., Chan, T., Sun, J., et al. (2005). Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 280:37481–37488.
  • Kottlors, M., Jaksch, M., Ketelsen, U. P., Weiner, S., Glocker, F. X., Lücking, C. H. (2001). Valproic acid triggers acute rhabdomyolysis in a patient with carnitine palmitoyltransferase type II deficiency. Neuromusc Disord 11:757–759.
  • Kovari, H., Ledergerber, B., Peter, U., Flepp, M., Jost, J., Schmid, P., et al.; Swiss HIV Cohort Study. (2009). Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis 49:626–635.
  • Kowaltowski, A. J., Castilho, R. F., Vercesi, A. E. (2001). Mitochondrial permeability transition and oxidative stress. FEBS Lett 495:12–15.
  • Krähenbühl, S., Brandner, S., Kleinle, S., Liechti, S., Straussmann, D. (2000). Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure. Liver 20:346–348.
  • Kretz-Rommel, A., Boelsterli, U. A. (1995). Cytotoxic activity of T cells and non-T cells from diclofenac-immunized mice against cultured syngeneic hepatocytes exposed to diclofenac. Hepatology 22:213–222.
  • Kroon, A. M., de Vries, H. (1969). The effects of chloramphenicol on the biogenesis of mitochondria of rat liver in vivo. FEBS Lett 3:208–210.
  • Kubota, T., Fujisaki, K., Itoh, Y., Yano, T., Sendo, T., Oishi, R. (2004). Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Biochem Pharmacol 67:2175–2186.
  • Kukielka, E., Cederbaum, A. I. (1989). NADH-dependent microsomal interaction with ferric complexes and production of reactive oxygen species. Arch Biochem Biophys 275:540–550.
  • Kukielka, E., Dicker, E., Cederbaum, A. I. (1994). Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. Arch Biochem Biophys 309:377–386.
  • Kupsch, K., Hertel, S., Kreutzmann, P., Wolf, G., Wallesch, C. W., Siemen, D., et al. (2009). Impairment of mitochondrial function by minocycline. FEBS J 276:1729–1738.
  • Kurosaki, M., Takagi, H., Mori, M. (2000). HLA-A33/B44/DR6 is highly related to intrahepatic cholestasis induced by tiopronin. Dig Dis Sci 45:1103–1108.
  • Kurtovic, J., Riordan, S. M. (2003). Paracetamol-induced hepatotoxicity at recommended dosage. J Intern Med 253:240–243.
  • Labbe, G., Descatoire, V., Beaune, P., Lettéron, P., Larrey, D., Pessayre, D. (1989). Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety. J Pharmacol Exp Ther 250:1034–1042.
  • Labbe, G., Fromenty, B., Fréneaux, E., Morzelle, V., Lettéron, P., Berson, A., et al. (1991). Effects of various tetracycline derivatives on in vitro and in vivo β-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice. Biochem Pharmacol 41:638–641.
  • Laine, J. E., Auriola, S., Pasanen, M., Juvonen, R. O. (2009). Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. Xenobiotica 39:11–21.
  • Lake, B. G., Gaudin, H., Price, R. J., Walters, D. G. (1992). Metabolism of [3-14C]coumarin to polar and covalently bound products by hepatic microsomes from the rat, Syrian hamster, gerbil, and humans. Food Chem Toxicol 30:105–115.
  • Lam, C. W., Lau, C. H., Williams, J. C., Cahn, Y. W., Wong, L. J. C. (1997). Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) triggered by valproate therapy. Eur J Pediatr 156:562–564.
  • Lammert, C., Einarsson, S., Saha, C., Niklasson, A., Bjornsson, E., Chalasani, N. (2008). Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology 47:2003–2009.
  • Lammert, C., Bjornsson, E., Niklasson, A., Chalasani, N. (2010). Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology 51:615–620.
  • Landriscina, M., Maddalena, F., Laudiero, G., Esposito, F. (2009). Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Signal 11:2701–2716.
  • Larosche, I., Letteron, P., Fromenty, B., Vadrot, N., Abbey-Toby, A., Feldmann, G., et al. (2007). Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver. J Pharmacol Exp Ther 321:526–535.
  • Larosche, I., Choumar, A., Fromenty, B., Lettéron, P., Abbey-Toby, A., Van Remmen, H., et al. (2009). Prolonged ethanol administration depletes mitochondrial DNA in MnSOD-overexpressing transgenic mice, but not in their wild type littermates. Toxicol Appl Pharmacol 234:326–338.
  • Larosche, I., Letteron, P., Berson, A., Fromenty, B., Huang, T. T., Moreau, R., et al. (2010). Hepatic mitochondrial DNA depletion after an alcohol binge in mice: probable role of peroxynitrite and modulation by manganese superoxide dismutase. J Pharmacol Exp Ther 332:886–397.
  • Larrey, D., Castot, A., Pessayre, D., Mérigot, P., Machayekhy, J. P., Feldmann, G., et al. (1986a). Amodiaquine-induced hepatitis. A report of seven cases. Ann Intern Med 104:801–803.
  • Larrey, D., Lettéron, P., Foliot, A., Descatoire, V., Degott, C., Genève, J., et al. (1986b). Effects of pregnancy on the toxicity and metabolism of acetaminophen in mice. J Pharmacol Exp Ther 237:283–291.
  • Larrey, D., Berson, A., Habersetzer, F., Tinel, M., Castot, A., Babany, G., et al. (1989a). Genetic predisposition to drug hepatotoxicity. Role in hepatitis caused by amineptine, a tricyclic antidepressant. Hepatology 10:168–173.
  • Larrey, D., Tinel, M., Amouyal, G., Fréneaux, E., Berson, A., Fouin-Fortunet, H., et al. (1989b). Genetically determined oxidation polymorphism and drug hepatotoxicity. Study of 51 patients. J Hepatol 8:158–164.
  • Larrey, D., Tinel, M., Lettéron, P., Maurel, P., Loeper, J., Belghiti, J., et al. (1990). Metabolic activation of the new tricyclic antidepressant tianeptine by human liver cytochrome P450. Biochem Pharmacol 40:545–550.
  • Lasfer, M., Davenne, L., Vadrot, N., Alexia, C., Sadji-Ouatas, Z., Bringuier, A. F., et al. (2006). Protein kinase PKC delta and c-Abl are required for mitochondrial apoptosis induction by genotoxic stress in the absence of p53, p73 and Fas receptor. FEBS Lett 580:2547–2552.
  • Lauressergues, E., Staels, B., Valeille, K., Majd, Z., Hum, D. W., Duriez, P., et al. (2010). Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes. Naunyn Schmiedebergs Arch Pharmacol 381:427–439.
  • Lawrence, J. W., Darkin-Rattray, S., Xie, F., Neims, A. H., Rowe, T. C. (1993). 4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells. J Cell Biochem 51:165–174.
  • Lawrence, J. W., Claire, D. C., Weissig, V., Rowe, T. C. (1996). Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Mol Pharmacol 50:1178–1188.
  • Lazarczyk, D. A., Goldstein, N. S., Gordon, S. C. (2001). Trovafloxacin hepatotoxicity. Dig Dis Sci 46:925–926.
  • Lebrecht, D., Vargas-Infante, Y. A., Setzer, B., Kirschner, J., Walker, U. A. (2007). Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice. Hepatology 45:72–79.
  • Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J., Robertson, G. R. (2000). CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105:1067–1075.
  • Le Dinh, T., Fréneaux, E., Labbe, G., Lettéron, P., Degott, C., Genève, J., et al. (1988). Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 247:745–750.
  • Lee, S. K., Kim, Y. C., Song, S. B., Kim, Y. S. (2010). Stabilization and translocation of p53 to mitochondria is linked to Bax translocation to mitochondria in simvastatin-induced apoptosis. Biochem Biophys Res Commun 391:1592–1597.
  • Leist, M., Single, B., Castoldi, A. F., Kühnle, S., Nicotera, P. (1997). Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185:1481–1486.
  • Leonarduzzi, G., Scavazza, A., Biasi, F., Chiarpotto, E., Camandola, S., Vogl, S., et al. (1997). The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor ß1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 11:851–857.
  • Le Roy, F., Bisbal, C., Silhol, M., Martinand, C., Lebleu, B., Salehzada, T. (2001). The 2-5A/RNase L/RNase inhibitor (RLI) pathway regulates mitochondrial mRNAs stability in interferon-α-treated H9 cells. J Biol Chem 276:48473–48482.
  • Le Roy, F., Silhol, M., Salehzada, T., Bisbal, C. (2007). Regulation of mitochondrial mRNA stability by RNase L is translation-dependent and controls IFNalpha-induced apoptosis. Cell Death Differ 14:1406–1413.
  • Lettéron, P., Fouin-Fortunet, H., Tinel, M., Danan, G., Belghiti, J., Pessayre, D. (1984). Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450. J Pharmacol Exp Ther 229:845–850.
  • Lettéron, P., Duchatelle, V., Berson, A., Fromenty, B., Fisch, C., Degott, C., et al. (1993). Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol abusers. Gut 34:409–414.
  • Lettéron, P., Brahimi-Bourouina, N., Robin, M. A., Moreau, A., Feldmann, G., Pessayre, D. (1997). Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid β-oxidation. Am J Physiol 272(Gastrointest Liver Physiol 35):G1141–G1150.
  • Lettéron, P., Sutton, A., Mansouri, A., Fromenty, B., Pessayre, D. (2003). Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology 38:133–140.
  • Levy, R. H., Rettenmeier, A. W., Anderson, G. D., Wilensky, A. J., Friel, P. N., Baillie, T. A., et al. (1990). Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid. Clin Pharmacol Ther 48:225–235.
  • Lewis, W., Dalakas, M. C. (1995). Mitochondrial toxicity of antiviral drugs. Nat Med 1:417–422.
  • Lewis, J. A., Huq, A., Najarro, P. (1996a). Inhibition of mitochondrial function by interferon. J Biol Chem 22:13184–13190.
  • Lewis, W, Levine, ES, Griniuviene, B, Tankersley, KO, Colacino, JM, Sommadossi, JP, et al. (1996b). Fialuridine and its metabolites inhibit DNA polymerase γ at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. Proc Natl Acad Sci U S A 93:3592–3597.
  • Lewis, W., Copeland, W. C., Day, B. J. (2001). Mitochondrial DNA depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors. Lab Invest 81:777–790.
  • Li, T. K., Liu, L. F. (2001). Tumor cell death induced by topoisomerase-targeting drugs. Annu Rev Pharmacol Toxicol 41:53–77.
  • Li, H., Zhu, H., Xu, C., Yuan, J. (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491–501.
  • Li, F., Chordia, M. D., Huang, T., Macdonald, T. L. (2009a). In vitro nimesulide studies toward understanding idiosyncratic hepatotoxicity: diiminoquinone formation and conjugation. Chem Res Toxicol 22:72–80.
  • Li, X., Kamenecka, T. M., Cameron, M. D. (2009b). Bioactivation of the epidermal growth factor receptor inhibitor gefitinib: implications for pulmonary and hepatic toxicities. Chem Res Toxicol 22:1736–1742.
  • Li, X., Kamenecka, T. M., Cameron, M. D. (2010). Cytochrome P450-mediated bioactivation of the epidermal growth factor receptor inhibitor erlotinib to a reactive electrophile. Drug Metab Dispos 38:1238–1245.
  • Liguori, M. J., Anderson, M. G., Bukofzer, S., McKim, J., Pregenzer, J. F., Retief, J., et al. (2005). Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin. Hepatology 41:177–186.
  • Lillibridge, J. H., Amore, B. M., Slattery, J. T., Kalhorn, T. F., Nelson, S. D., Finnell, R. H., et al. (1997). Protein-reactive metabolites of carbamazepine in mouse liver microsomes. Drug Metab Dispos 24:509–514.
  • Lin, J. H., Castora, F. J. (1991). DNA topoisomerase II from mammalian mitochondria is inhibited by the antitumor drugs, m-ASA, and VM-26. Biochem Biophys Res Commun 176: 690–697.
  • Lin, M. C. M., Li, J. J., Wang, E. J., Princler, G. L., Kauffman, F. C., Kung, H. F. (1997). Ethanol down-regulates the transcription of microsomal triglyceride transfer protein gene. FASEB J 11:1145–1152.
  • Liu, Z. C., Uetrecht, J. P. (2000). Metabolism of ticlopidine by activated neutrophils: implications for ticlopidine-induced agranulocytosis. Drug Metab Dispos 28:726–730.
  • Liu, P., Demple, B. (2010). DNA repair in mammalian mitochondria: much more than we thought? Environ Mol Mutagen 51:417–426.
  • Loeper, J., Descatoire, V., Amouyal, G., Lettéron, P., Larrey, D., Pessayre, D. (1989). Presence of covalently bound metabolites on rat hepatocyte plasma membrane proteins after administration of isaxonine, a drug leading to immunoallergic hepatitis in man. Hepatology 9:675–678.
  • Loeper, J., Descatoire, V., Maurice, M., Beaune, P., Feldmann, G., Larrey, D., et al. (1990). Presence of functional cytochrome P-450 on isolated rat hepatocyte plasma membrane. Hepatology 11:850–858.
  • Loeper, J., Descatoire, V., Maurice, M., Beaune, P., Belghiti, J., Houssin, D., et al. (1993). Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology 104:203–216.
  • Loeper, J., Descatoire, V., Letteron, P., Moulis, C., Degott, C., Dansette, P., et al. (1994). Hepatotoxicity of germander in mice. Gastroenterology 106:464–472.
  • Lopez Garcia, M. P., Dansette, P. M., Valadon, P., Amar, C., Beaune, P. H., Guengerich, F. P., et al. (1993). Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10. Eur J Biochem 213:223–232.
  • Lucena, MI, Andrade, RJ, Martínez, C, Ulzurrun, E, García-Martín, E, Borraz, Y, et al.; Spanish Group for the Study of Drug-Induced Liver Disease. (2008). Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury. Hepatology 48:588–596.
  • Lucena, MI, García-Martín, E, Andrade, RJ, Martínez, C, Stephens, C, Ruiz, JD, et al. (2010). Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury. Hepatology 52:303–312.
  • Lucena, MI, Molokhia, M, Shen, Y, Urban, TJ, Aithal, GP, Andrade, RJ, et al.; Spanish Dili Registry, EUDRAGENE, DILIN, DILIGEN,,and International SAEC. (2011). Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology Apr 12. [Epub ahead of print]
  • Luef, G. J., Waldmann, M., Sturm, W., Naser, A., Trinka, E., Unterberger, I., et al. (2004). Valproate therapy and nonalcoholic fatty liver disease. Ann Neurol 55:729–732.
  • Lund, K. C., Peterson, L. L., Wallace, K. B. (2007). Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs. Antimicrob Agents Chemother 51:2531–2539.
  • Lynx, M. D., McKee, E. E. (2006). 3′-Azido-3′-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria. Biochem Pharmacol 72:239–243.
  • MacDonald, M. G., McGrath, P. P., McMartin, D. N., Washington, G. C., Hudak, G. (1984). Potentiation of the toxic effects of acetaminophen in mice by concurrent infection with influenza B virus: a possible mechanism for Reye′s syndrome. Pediatr Res 18:181–187.
  • McDonald, M. G., Rettie, A. E. (2007). Sequential metabolism and bioactivation of the hepatotoxin benzbromarone: formation of glutathione adducts from a catechol intermediate. Chem Res Toxicol 20:1833–1842.
  • McKenzie, R, Fried, MW, Sallie, R, Conjeevaram, H, Di Biseglie, AM, Park, Y, et al. (1995). Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. New Engl J Med 333:1099–1105.
  • Maggs, J. L., Kitteringham, N. R., Breckenridge, A. M., Park, B. K. (1987). Autoxidative formation of a chemically reactive intermediate from amodiaquine, a myelotoxin and hepatotoxin in man. Biochem Pharmacol 36:2061–2062.
  • Maida, I., Núñez, M., Ríos, M. J., Martín-Carbonero, L., Sotgiu, G., Toro, C., et al. (2006). Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr 42:177–182.
  • Majamaa, K, Moilanen, JS, Uimonen, S, Remes, AM, Salmela, PI, Kärppä, M, et al. (1998). Epidemiology of the A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Human Genet 63:447–454.
  • Mallon, PWG, Unemori, P, Sedwell, R, Morey, A, Rafferty, M, Williams, K, et al., and the SAMA investigators (2005). In vivo, nucleoside reverse transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. J Infect Dis 191:1686–1696.
  • Mandel, H., Hartman, C., Berkowitz, D., Elpeleg, O. N., Manov, I., Iancu, T. C. (2001). The hepatic mitochondrial DNA depletion syndrome: ultrastructural changes in liver biopsies. Hepatology 34:776–784.
  • Mansouri, A., Fromenty, B., Berson, A., Robin, M. A., Grimbert, S., Beaugrand, M., et al. (1997). Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol 27:96–102.
  • Mansouri, A, Gaou, I, De Kerguenec, C, Amsellem, S, Haouzi, D, Berson, A, et al. (1999). An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 117:181–190.
  • Mansouri, A., Demeilliers, C., Amsellem, S., Pessayre, D., Fromenty, B. (2001). Acute ethanol administration oxidatively damages and depletes mitochondrial DNA in mouse liver, brain, heart, and skeletal muscles. Protective effects of antioxidants. J Pharmacol Exp Ther 298:737–743.
  • Mansouri, A., Haouzi, D., Descatoire, V., Demieilliers, C., Sutton, A., Vadrot, N., et al. (2003). Tacrine inhibits topoisomerases and DNA synthesis to cause mitochondrial DNA depletion and apoptosis in mouse liver. Hepatology 38:715–725.
  • Mansuy, D. (1978). Coordination chemistry of cytochromes P 450 and iron-porphyrins: relevance to pharmacology and toxicology. Biochimie 60:969–977.
  • Maria, V. A., Pinto, L., Victorino, R. M. (1994). Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis. J Hepatol 21:151–158.
  • Martin, A. M., Hammond, E., Nolan, D., Pace, C., Boer, M. D., Taylor, L., et al. (2003). Accumulations of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse transcriptase inhibitors. Am J Hum Genet 72:549–560.
  • Martin, A. M., Nolan, D., James, I., Cameron, P., Keller, J., Moore, C., et al. (2005). Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts. AIDS 19:97–99.
  • Masubuchi, Y., Nakayama, S., Horie, T. (2002). Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats. Hepatology 35:544–551.
  • Masubuchi, Y., Suda, C., Horie, T. (2005). Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol 42:110–116.
  • Masubuchi, Y., Kano, S., Horie, T. (2006). Mitochondrial permeability transition as a potential determinant of antidiabetic thiazolidinediones. Toxicology 222:233–239.
  • Masubuchi, N., Makino, C., Murayama, N. (2007). Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans. Chem Res Toxicol 20:455–464.
  • Meister, A. (1995). Glutathione biosynthesis and its inhibition. Meth Enzymol 252:26–30.
  • Melegh, B., Pap, M., Molnár, D., Masszi, G., Kopcsányi, G. (1997). Carnitine administration ameliorates the changes in energy metabolism caused by short-term pivampicillin medication. Eur J Pediatr 156:795–799.
  • Menor, C., Fernández-Moreno, M. D., Fueyo, J. A., Escribano, O., Olleros, T., Arriaza, E., et al. (2004). Azathioprine acts upon rat hepatocyte mitochondria and stress-activated protein kinases leading to necrosis: protective role of N-acetyl-L-cysteine. J Pharmacol Exp Ther 311:668–676.
  • Mercer, A. E., Regan, S. L., Hirst, C. M., Graham, E. E., Antoine, D. J., Benson, C. A., et al. (2009). Functional and toxicological consequences of metabolic bioactivation of methapyrilene via thiophene S-oxidation: induction of cell defence, apoptosis and hepatic necrosis. Toxicol Appl Pharmacol 239:297–305.
  • Miller, M. E., Brooks, J. G., Forbes, N., Insel, R. (1992). Frequency of medium-chain acyl-CoA dehydrogenase deficiency G-985 mutation in sudden infant death syndrome. Pediatr Res 31:305–307.
  • Mita, E., Hayashi, N., Lio, S., Takehara, T., Hijioka, T., Kasahara, A., et al. (1994). Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 204:468–474.
  • Mitchell, J. R., Jollow, D. J. (1975). Metabolic activation of drugs to toxic substances. Gastroenterology 68:392–410.
  • Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., Brodie, B. B. (1973). Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187:211–217.
  • Mitchell, J. R., Long, M. W., Thorgeirsson, U. P., Jollow, D. J. (1975). Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest 68:181–190.
  • Mitchell, J. R., Nelson, W. L., Potter, W. Z., Sasame, H. A., Jollow, D. J. (1976). Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J Pharmacol Exp Ther 199:41–52.
  • Mitsuya, H., Broder, S. (1986). Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc Natl Acad Sci U S A 83:1911–1915.
  • Miyako, K., Kai, Y., Irie, T., Takeshige, K., Kang, D. (1997). The content of intracellular mitochondrial DNA is decreased by 1-methyl-4-phenylpyridium ion (MPP+). J Biol Chem 272:9605–9608.
  • Mizutani, T., Yoshida, K., Murakami, M., Shirai, M., Kawazoe, S. (2000). Evidence for the involvement of N-methylthiourea, a ring cleavage metabolite, in the hepatotoxicity of methimazole in glutathione-depleted mice: structure-toxicity and metabolic studies. Chem Res Toxicol 13:170–176.
  • Moll, U. M., Wolff, S., Speidel, D., Deppert, W. (2005). Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol 17:631–636.
  • Montalto de Mecca, M., Diaz, E. G., Castro, J. (2002). Nifurtimox biotransformation to reactive metabolites or nitrite in liver subcellular fractions and model systems. Toxicol Lett 136:1–8.
  • Montenez, J. P., Van Bambeke, F., Piret, J., Brasseur, R., Tulkens, P. M., Mingeot-Leclercq, M. P. (1999). Interactions of macrolide antibiotics (erythromycin A, roxithromycin, erythromycylamine [dirithromycin], and azithromycin) with phospholipids: computer-aided conformation analysis and studies on acellular and cell culture models. Toxicol Appl Pharmacol 156:129–140.
  • Morgan, M. Y., Reshef, R., Shah, R. R., Oates, N. S., Smith, R. L., Sherlock, S. (1984). Impaired oxidation of debrisoquine in patients with perhexiline liver injury. Gut 10:1057–1064.
  • Morris, A. A. M. (1999). Mitochondrial respiratory chain disorders and the liver. Liver 19:357–368
  • Morris, A. A. M., Taanman, J. W., Blake, J., Cooper, J. M., Lake, B. D., Malone, M., et al. (1998). Liver failure associated with mitochondrial DNA depletion. J Hepatol 28:556–563.
  • Moult, P. J., Sherlock, S. (1975). Halothane-related hepatitis. A clinical study of twenty-six cases. Q J Med 44:99–114.
  • Mullauer, F. B., Kessler, J. H., Medema, J. P. (2009). Betulinic acid induces cytochrome c release and apoptosis in a Bax/Bak-independent, permeability transition pore dependent fashion. Apoptosis 14:191–202.
  • Murphy, M. J., Piper, L. J., McMartin, D. N., Kaminsky, L. S. (1980). The role of cytochrome P-450-inducing agents in potentiating the toxicity of fluroxene (2,2,2-trifluoroethyl vinyl ether). Toxicol Appl Pharmacol 52:69–81.
  • Nadanaciva, S., Bernal, A., Aggeler, R., Capaldi, R., Will, Y. (2007a). Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. Toxicol In Vitro 21:902–911.
  • Nadanaciva, S., Dykens, J. A., Bernal, A., Capaldi, R. A., Will, Y. (2007b). Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration. Toxicol Appl Pharmacol 223:277–287.
  • Nagy, G., Kardon, T., Wunderlich, L., Szarka, A., Kiss, A., Schaff, Z., et al. (2007). Acetaminophen induces ER dependent signaling in mouse liver. Arch Biochem Biophys 459:273–279.
  • Nahon, P., Sutton, A., Pessayre, D., Rufat, P., Degoul, F., Ganne-Carrie, N., et al. (2005). Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death. Clin Gastroenterol Hepatol 3:292–398.
  • Nakagawa, H., Maeda, S., Hikiba, Y., Ohmae, T., Shibata, W., Yanai, A., et al. (2008). Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology 135:1311–1321.
  • Nakamura, A., Nakajima, M., Higashi, E., Yamanaka, H., Yokoi, T. (2008). Genetic polymorphisms in the 5′-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation. Pharmacogenet Genomics 18:709–720.
  • Narimatsu, S, Arai, T, Watanabe, T, Masubuchi, Y, Horie, T, Suzuki, T, et al. (1997). Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat. Chem Res Toxicol 10:289–295.
  • Nass, M. M. (1984). Analysis of methylglyoxal bis(guanylhydrazone)-induced alterations of hamster tumor mitochondria by correlated studies of selective rhodamine binding, ultrastructural damage, DNA replication, and reversibility. Cancer Res 44:2677–2688.
  • Natarajan, S. K., Thangaraj, K. R., Eapen, C. E., Ramachandran, A., Mukhopadhya, A., Mathai, M., et al. (2010). Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress. Hepatology 51:191–200.
  • Natori, S., Rust, C., Stadheim, L. M., Srinivasan, A., Burgart, L. J., Gores, G. J. (2001). Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 34:248–253.
  • Nechushtan, A., Smith, C. L., Lamensdorf, I., Yoon, S. H., Youle, R. J. (2001). Bax and Bak coalesce into mitochondria-associated clusters during apoptosis. J Cell Biol 153:1265–1276.
  • Nelson, S. D., Mitchell, J. R., Snodgrass, W. R., Timbrell, J. A. (1978). Hepatotoxicity and metabolism of iproniazid and isopropylhydrazine. J Pharmacol Exp Ther 206:574–585.
  • Neuberger, J., Williams, R. (1989). Immune mechanisms in tienilic acid associated hepatotoxicity. Gut 30:515–519.
  • Neuberger, J., Kenna, J. G., Aria, K. N., Williams, R. (1985). Antibody mediated hepatocyte injury in methyl-dopa induced hepatotoxicity. Gut 26:1233–1239.
  • Nguyen, G. C., Sam, J., Thuluvath, P. J. (2008). Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology 48:1336–1341.
  • Nishikawa, Y., Ukida, M., Matsuo, R., Omori, N., Tsuji, T. (1994). Ca2+ influx initiates death of hepatocytes injured by activation of complement. Liver 14:200–205.
  • Nishiya, Y., Hagihara, K., Kurihara, A., Okudaira, N., Farid, N. A., Okazaki, O., et al. (2009). Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel. Xenobiotica 39:836–843.
  • Njoku, D. B., Greenberg, R. S., Bourdi, M., Borkowf, C. B., Dake, E. M., Martin, J. L., et al. (2002). Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists. Anesth Analg 94:243–249.
  • Njølstad, P. R., Skjeldal, O. H., Agsteribbe, E., Huckriede, A., Wannag, E., Søvik, O., et al. (1997). Medium chain acyl-CoA dehydrogenase deficiency and fatal valproate toxicity. Pediatr Neurol 16:160–162.
  • Noda, S., Umezaki, H., Yamamoto, K., Araki, T., Murakami, T., Ishii, N. (1988). Reye-like syndrome following treatment with the pantothenic acid antagonist, calcium hopantenate. J Neurol Neurosurg Psychiatry 51:582–585.
  • Nordmann, R., Ribière, C., Rouach, H. (1992). Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radical Biol Med 112:219–240.
  • Notley, L. M., De Wolf, C. J., Wunsch, R. M., Lancaster, R. G., Gillam, E. M. (2002). Bioactivation of tamoxifen by recombinant human cytochrome p450 enzymes. Chem Res Toxicol 15:614–622.
  • Núñez, M. (2010). Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology 52:1143–1155.
  • O′Brien, P. J. (1991). Molecular mechanisms of quinone cytotoxicity. Chem Biol Interac 80:1–41.
  • O′Donohue, J., Oien, K. A., Donaldson, P., Underhill, J., Clare, M., MacSween, R. N., et al. (2000). Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 47:717–720.
  • Oesch, F., Daly, J. (1972). Conversion of naphthalene to trans-naphthalene dihydrodiol: evidence for the presence of a coupled aryl monooxygenase-epoxide hydrase system in hepatic microsomes. Biochem Biophys Res Commun 46:1713–1720.
  • Oh, K. W., Qian, T., Brenner, D. A., Lemasters, J. J. (2003). Salicylate enhances necrosis and apoptosis mediated by the mitochondrial permeability transition. Toxicol Sci 73:44–52.
  • Ohnishi, T., Ogawa, Y., Saibara, T., Nishioka, A., Kariya, S., Fukumoto, M., et al. (2005). CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients. Oncol Rep 13:485–489.
  • Okanoue, T., Sakamoto, S., Itoh, Y., Minami, M., Yasui, K., Sakamoto, M., et al. (1996). Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 25:283–291.
  • Oleinick, N. L., Corcoran, J. W. (1969). Two types of binding of erythromycin to ribosomes from antibiotic-sensitive and resistant Bacillus subtilis 168. J Biol Chem 244:727–735.
  • Olsen, J., Bjørnsdottir, I., Tjørnelund, J., Honoré Hansen, HansenS.. (2002). Chemical reactivity of the naproxen acyl glucuronide and the naproxen coenzyme A thioester towards bionucleophiles. J Pharm Biomed Anal 29:7–15.
  • Ortiz de Montellano, P. R., Beilan, H. S., Kunze, K. L. (1981). N-alkylprotoporphyrin IX formation in 3,5-dicarbethoxy-1,4-dihydrocollidine-treated rats. Transfer of the alkyl group from the substrate to the porphyrin. J Biol Chem 256:6708–6713.
  • Osborn, S. L., Diehl, G., Han, S. J., Xue, L., Kurd, N., Hsieh, K., et al. (2010). Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc Natl Acad Sci U S A 107:13034–13039.
  • Ott, M., Gogvadze, V., Orrenius, S., Zhivotovsky, B. (2007). Mitochondria, oxidative stress and cell death. Apoptosis 12:913–922.
  • Oyadomari, S., Mori, M. (2004). Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11:381–389.
  • Pan, Z., Bhat, M. B., Nieminen, A. L., Ma, J. (2001). Synergistic movements of Ca(2+) and Bax in cells undergoing apoptosis. J Biol Chem 276:32257–32263.
  • Pantarotto, C., Arboix, M., Sezzano, P., Abbruzzi, R. (1982). Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins. Biochem Pharmacol 31:1501–1507.
  • Paquet, C., Sané, A. T., Beauchemin, M., Bertrand, R. (2005). Caspase- and mitochondrial dysfunction-dependent mechanisms of lysosomal leakage and cathepsin B activation in DNA damage-induced apoptosis. Leukemia 19:784–779.
  • Partin, J. S., Daugherty, C. C., McAdams, A. J., Partin, J. C., Schubert, W. K. (1984). A comparison of liver ultrastructure in salicylate intoxication and Reye′s syndrome. Hepatology 4:687–690.
  • Penzo, D., Petronilli, V., Angelin, A., Cusan, C., Colonna, R., Scorrano, L., et al. (2004). Arachidonic acid released by phospholipase A(2) activation triggers Ca(2+)-dependent apoptosis through the mitochondrial pathway. J Biol Chem 279:25219–25225.
  • Pérez-Carreras, M., Del Hoyo, P., Martin, M. A., Rubio, J. C., Martin, A., Castellano, G., et al. (2003). Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38:999–1007.
  • Pérez-Sala, D., Mollinedo, F. (1994). Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem Biophys Res Commun 199:1209–1215.
  • Pessayre, D. (1995). Role of reactive metabolites in drug-induced hepatitis. J Hepatol 23: S16–S24
  • Pessayre, D. (2007). Mitochondria and energy formation. In: Rodes, J., Benhamou, J. P., Blei, A. T., Reichen, J., Rizzetto, M. (Eds.), Textbook of hepatology: from basic science to clinical practice, third ed. ( pp. 149–165). Oxford, UK: Blackwell.
  • Pessayre, D., Fromenty, B. (2005). NASH: a mitochondrial disease. J Hepatol 42:928–940.
  • Pessayre, D., Larrey, D. (2007). Drug-induced liver injury. In: Rodes, J., Benhamou, J. P., Blei, A. T., Reichen, J., Rizzetto, M. (Eds.), Textbook of hepatology: from basic science to clinical practice (pp. 1211–1268). Oxford, UK: Blackwell.
  • Pessayre, D., Mazel, P. (1976). Induction and inhibition of hepatic drug metabolizing enzymes by rifampin. Biochem Pharmacol 25:943–949.
  • Pessayre, D., Bentata, M., Degott, C., Nouel, O., Miguet, J. P., Rueff, B., et al. (1977). Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology 72:284–289.
  • Pessayre, D., Allemand, H., Benoist, C., Afifi, F., François, M., Benhamou, J. P. (1978a). Effect of surgery under general anaesthesia on antipyrine clearance. Br J Clin Pharmacol 6:505–513.
  • Pessayre, D., de Saint-Louvent, P., Degott, C., Bernuau, J., Rueff, B., Benhamou, J. P. (1978b). Iproclozide fulminant hepatitis. Possible role of enzyme induction. Gastroenterology 75:492–496.
  • Pessayre, D., Bichara, M., Feldmann, G., Degott, C., Potet, F., Benhamou, J. P. (1979a). Perhexiline maleate-induced cirrhosis. Gastroenterology 76:170–177.
  • Pessayre, D., Dolder, A., Artigou, J.Y., Wandscheer, J. C., Descatoire, V., Degott, C., et al. (1979b). Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology 77:264–271.
  • Pessayre, D., Wandscheer, J. C., Cobert, B., Level, R., Degott, C., Batt, A. M., et al. (1980). Additive effects of inducers and fasting on acetaminophen hepatotoxicity. Biochem Pharmacol 29:219–223.
  • Pessayre, D., Descatoire, V., Konstantinova-Mitcheva, M., Wandscheer, J. C., Cobert, B., Level, R., et al. (1981). Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450. Biochem Pharmacol 30:553–558.
  • Pessayre, D., Tinel, M., Larrey, D., Cobert, B., Funck-Brentano, C., Babany, G. (1983). Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione. J Pharmacol Exp Ther 224:685–691.
  • Pessayre, D., Larrey, D., Funck-Brentano, C., Benhamou, J. P. (1985). Drug interactions and hepatitis produced by some macrolide antibiotics. J Antimicrob Chemother 16(Suppl A):181–194.
  • Pessayre, D., Haouzi, D., Fau, D., Robin, M. A., Mansouri, A., Berson, A. (1999). Withdrawal of life support, altruistic suicide, fratricidal killing, and euthanasia by lymphocytes: different forms of drug-induced hepatic apoptosis. J Hepatol 31:760–770.
  • Pessayre, D., Feldmann, G., Haouzi, D., Fau, D., Moreau, A., Neuman, M. (2000). Hepatocyte apoptosis triggered by natural substances (cytokines, other endogenous substances, and foreign toxins). In: Cameron, R. G., Feuer, G. (Eds), Apoptosis and its modulation by drugs. Heidelberg: Springer Verlag; Handbook Exp Pharmacol 142:59–108.
  • Pessayre, D., Fromenty, B., Mansouri, A., Berson, A. (2007). Hepatotoxicity due to mitochondrial dysfunction. In: Kaplowitz, N., DeLeve, L. D. (Eds.), Drug-induced liver disease, second ed. ( pp. 49–84). New York: Informa Healthcare USA.
  • Pessayre, D., Mansouri, A., Berson, A., Fromenty, B. (2010). Mitochondrial involvement in drug-induced liver injury. Handb Exp Pharmacol 196:311–365.
  • Peterson, G. R., Hostetler, R. M., Lehman, T., Covault, H. P. (1979). Acute inhibition of oxidative drug metabolism by propoxyphene (Darvon). Biochem Pharmacol 28:1783–1789.
  • Piccoli, C., Scrima, R., Quarato, G., D′Aprile, A., Ripoli, M., Lecce, L., et al. (2007). Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 46:58–65.
  • Pohl, L. R., Martin, J. L., George, J. W. (1980). Mechanism of metabolic activation of chloroform by rat liver microsomes. Biochem Pharmacol 29:3271–3276.
  • Polavarapu, R., Spitz, D. R., Sim, J. E., Follansbee, M. H., Oberley, L. W., Rahemtulla, A., et al. (1988). Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 27:1317–1323.
  • Polson, J. E., Ocama, P., Larson, A. M., Hynan, L., Lalani, E. K., Harrison, M. E., et al. (2003). Role of acetaminophen in acute liver failure due to viral hepatitis. Hepatology 38:544A.
  • Ponchaut, S., Van Hoof, F., Veitch, K. (1992). In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions. Biochem Pharmacol 43:2435–2442.
  • Pons, C., Dansette, P. M., Gregeois, J., Homberg, J. C., Billett, E. E., Mansuy, D. (1996). Human anti-mitochondria autoantibodies appearing in iproniazid-induced immunoallergic hepatitis recognize human liver monoamine oxidase B. Biochem Biophys Res Commun 218:118–124.
  • Poon, G. K., Chen, Q., Teffera, Y., Ngui, J. S., Griffin, P. R., Braun, M. P., et al. (2001). Bioactivation of diclofenac via benzoquinone imine intermediates-identification of urinary mercapturic acid derivatives in rats and humans. Drug Metab Dispos 29:1608–1613.
  • Poucell, S., Ireton, J., Valencia-Mayoral, P., Downar, E., Larratt, L., Patterson, J., et al. (1984). Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies. Gastroenterology 86:926–936.
  • Prokop, A., Wrasidlo, W., Lode, H., Herold, R., Lang, F., Henze, G., et al. (2003). Induction of apoptosis by enediyne antibiotic calicheamicin thetaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner. Oncogene 22:9107–9120.
  • Prox, A., Breyer-Pfaff, U. (1987). Amitriptyline metabolites in human urine. Identification of phenols, dihydrodiols, glycols, and ketones. Drug Metab Dispos 15:890–896.
  • Rachek, L. I., Yuzefovych, L. V., Ledoux, S. P., Julie, N. L., Wilson, G. L. (2009). Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes.Toxicol Appl Pharmacol 240:348–354.
  • Radi, R., Cassina, A., Hodara, R., Quijano, C., Castro, L. (2002). Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 33:1451–1464.
  • Raeder, M. B., Fernø, J., Vik-Mo, A. O., Steen, V. M. (2006). SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects? Mol Cell Biochem 289:167–173.
  • Rahmani, Z., Huh, K. W., Lasher, R., Siddiqui, A. (2000). Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 74:2840–2846.
  • Rauchenzauner, M., Haberlandt, E., Scholl-Bürgi, S., Karall, D., Schoenherr, E., Tatarczyk, T., et al. (2008). Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children. Epilepsy Res 80:142–149.
  • Ravagnan, L., Marzo, I., Costantini, P., Susin, S. A., Zamzami, N., Petit, P. X., et al. (1999). Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene 18:2537–2546.
  • Reed, G. A., Griffin, I. O., Eling, T. E. (1985). Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism. Mol Pharmacol 27:109–114.
  • Reid, A. B., Kurten, R. C., McCullough, S. S., Brock, R. W., Hinson, J. A. (2005). Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Ther 312:509–516.
  • Remington, P. L., Rowley, D., McGee, H., Hall, W. N., Monto, A. S. (1986). Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. Pediatrics 77:93–98.
  • Ress, B. D., Gross, E. M. (2000). Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. Ann Otol Rhinol Laryngol 109:435–437.
  • Rettenmeier, A. W., Prickett, K. S., Gordon, W. P., Bjorge, S. M., Chang, S. L., Levy, R. H., et al. (1985). Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates. Drug Metab Dispos 13:81–96.
  • Riedl, S. J., Salvesen, G. S. (2007). The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8:405–413.
  • Rigoulet, M., Devin, A., Avéret, N., Vandais, B., Guérin, B. (1996). Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol. Eur J Biochem 241:280–285.
  • Roberts, S. M., Harbison, R. D., James, R. C. (1991). Human microsomal N-oxidative metabolism of cocaine. Drug Metab Dispos 19:1046–1051.
  • Robin, M. A., Maratrat, M., Loeper, J., Durand-Schneider, A. M., Tinel, M., Ballet, F., et al. (1995). Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes. Gastroenterology 108:1110–1123.
  • Robin, M. A., Maratrat, M., Le Roy, M., Le Breton, F. P., Bonierbale, E., Dansette, P., et al. (1996). Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera. J Clin Invest 98:1471–1480.
  • Robin, M. A., Le Roy, M., Descatoire, V., Pessayre, D. (1997). Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. J Hepatol 26(Suppl 1):23–30.
  • Robin, M. A., Sauvage, I., Grandperret, T., Descatoire, V., Pessayre, D., Fromenty, B. (2005). Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes. FEBS Lett 579:6895–6902.
  • Robin, M. A., Albano, V., Pessayre, D., Berson, A. (2008). Steatohepatitis-inducing drugs trigger cytokeratin cross-links in hepatocytes. Possible contribution to Mallory-Denk body formation. Toxicol in Vitro 22:1511–1519.
  • Rodriguez, R. J., Proteau, P. J., Marquez, B. L., Hetherington, C. L., Buckholz, C. J., O′Connell, K. L. (1999). Flavin-containing monooxygenase-mediated metabolism of N-deacetyl ketoconazole by rat hepatic microsomes. Drug Metab Dispos 27:880–886.
  • Rosenberg, D. M., Meyer, A. A., Manning, I. H., Jr., Neelon, F. A. (1977). Acetaminophen and hepatic dysfunction in infectious mononucleosis. South Med J 70:660–661.
  • Rowe, P. C., Valle, D., Brusilow, S. W. (1988). Inborn errors of metabolism in children referred with Reye′s syndrome: a changing pattern. JAMA 260:3167–3170.
  • Rowe, T. C., Weissig, V., Lawrence, J. W. (2001). Mitochondrial DNA metabolism targeting drugs. Adv Drug Deliv Rev 49:175–187.
  • Roy, S., Francis, F. T., Born, C. K., Hamrick, M. E. (1980). Interaction of dantrolene with the hepatic mixed function oxidase system. Res Commun Chem Pathol Pharmacol 27:507–520.
  • Russmann, S., Jetter, A., Kullak-Ublick, G. A. (2010). Pharmacogenetics of drug-induced liver injury. Hepatology 52:748–761.
  • Sadeque, A. J. M., Fisher, M. B., Korzekwa, K. R., Gonzalez, F. J., Rettie, A. E. (1997). Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid. J Pharmacol Exp Ther 283:698–703.
  • Saha, S., New, L. S., Ho, H. K., Chui, W. K., Chan, E. C. (2010). Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytes.Toxicol Lett 195:135–141.
  • Samuel, C. E. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14:778–809.
  • Sancar, A., Lindsey-Boltz, L. A., Unsal-Kaçmaz, K., Linn, S. (2004). Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39–85.
  • Sanyal, A. J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., et al. (2001). Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183–1192.
  • Satoh, H., Fukuda, Y., Anderson, D. K., Ferrans, V. J., Gillette, J. R., Pohl, L. R. (1985). Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes. J Pharmacol Exp Ther 233:857–862.
  • Saudubray, J. M., Martin, D., de Lonlay, P., Touati, G., Poggi-Travert, F., Bonnet, D., et al. (1999). Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inher Metab Dis 22:488–502.
  • Sbarra, C., Castelli, M. G., Noseda, A., Fanelli, R. (1981). Pharmacokinetics of amineptine in man. Eur J Drug Metab Pharmacokinet 6:123–126.
  • Scharer, L., Smith, J. P. (1969). Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Ann Intern Med 71:1113–1120.
  • Schneider, E., Hsiang, Y. H., Liu, L. F. (1990). DNA topoisomerases as anticancer drug targets. Adv Pharmacol 21:149–183.
  • Schneider Berlin, K. R., Ammini, C. V., Rowe, T. C. (1998). Dequalinium induces a selective depletion of mitochondrial DNA from HeLa human cervical carcinoma cells. Exp Cell Res 245:137–145.
  • Schon, E. A., Bonilla, E., DiMauro, S. (1997). Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 29:131–149.
  • Seeff, L. B., Cuccherini, B. A., Zimmerman, H. J., Adler, E., Benjamin, S. B. (1986). Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 104:399–404.
  • Sepuri, N. B., Yadav, S., Anandatheerthavarada, H. K., Avadhani, N. G. (2007). Mitochondrial targeting of intact CYP2B1 and CYP2E1 and N-terminal truncated CYP1A1 proteins in Saccharomyces cerevisiae—role of protein kinase A in the mitochondrial targeting of CYP2E1. FEBS J 274:4615–4630.
  • Setzer, B., Lebrecht, D., Walker, U. A. (2008). Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine. Am J Pathol 172:681–690.
  • Shan, B., Vazquez, E., Lewis, J. A. (1990). Interferon selectively inhibits the expression of mitochondrial genes: a novel pathway for interferon-mediated responses. EMBO J 9:4307–4314.
  • Shaw, P. J., Ditewig, A. C., Waring, J. F., Liguori, M. J., Blomme, E. A., Ganey, P. E., et al. (2009a). Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury. Toxicol Sci 107:270–280.
  • Shaw, P. J., Ganey, P. E., Roth, R. A. (2009b). Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure. J Pharmacol Exp Ther 328:62–68.
  • Shear, N. H., Spielberg, S. P. (1988). Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 82:1826–1832.
  • Shear, N. H., Spielberg, S. P., Grant, D. M., Tang, B. K., Kalow, W. (1986). Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 105:179–183.
  • Shekhawat, P., Bennett, M. J., Sadovsky, Y., Nelson, D. M., Rakheja, D., Strauss, A. W. (2003). Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab 284: E1098–E1105
  • Shelnutt, S. R., Badger, T. M., Owens, S. M. (1996). Phencyclidine metabolite irreversible binding in the rat: gonadal steroid regulation and CYP2C11. J Pharmacol Exp Ther 277:292–298.
  • Shibata, M. A., Ito, Y., Morimoto, J., Otsuki, Y. (2004). Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism. Carcinogenesis 25:1887–1898.
  • Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., Guengerich, F. P. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–442.
  • Shishido, S., Koga, H., Harada, M., Kumemura, H., Hanada, S., Taniguchi, E., et al. (2003). Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes. Hepatology 37:136–147.
  • Silva, M. F. B., Ruiter, J. P. N., Ijlst, L., Jakobs, C., Duran, M., de Almeida, I. T., et al. (1997). Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation. J Inher Metab Dis 20:397–400.
  • Simon, T, Becquemont, L, Mary-Krause, M, de Waziers, I, Beaune, P, Funck-Brentano, C, et al. (2000). Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity. Clin Pharmacol Ther 67:432–437.
  • Singer, J. B., Lewitzky, S., Leroy, E., Yang, F., Zhao, X., Klickstein, L., et al. (2010). A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet 42:711–714
  • Sinha, B. K., Motten, A. G. (1982). Oxidative metabolism of hydralazine. Evidence for nitrogen centered radicals formation. Biochem Biophys Res Commun 105:1044–1051.
  • Sipes, I. G., Gandolfi, A. J., Pohl, L. R., Krishna, G., Brown, B. R. Jr. (1980). Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane. J Pharmacol Exp Ther 214:716–720.
  • Siproudhis, L., Beaugrand, M., Malledant, Y., Brissot, P., Guguen-Guillouzo, C., Guillouzo, A. (1991). Use of adult human hepatocytes in primary culture for the study of clometacin-induced immunoallergic hepatitis. Toxicity In Vitro 5:529–534.
  • Sirvent, P., Mercier, J., Vassort, G., Lacampagne, A. (2005). Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle. Biochem Biophys Res Commun 329:1067–1075.
  • Smith, K. S., Smith, P. L., Heady, T. N., Trugman, J. M., Harman, W. D., Macdonald, T. L. (2003). In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity. Chem Res Toxicol 16:123–128.
  • Snow, K. L., Moseley, R. H. (2007). Effect of thiazolidinediones on bile acid transport in rat liver. Life Sci 80:732–740.
  • Song, S., Wheeler, L. J., Mathews, C. K. (2003). Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. J Biol Chem 278:43893–43896.
  • Spielberg, S. P., Gordon, G. B. (1981). Glutathione synthetase-deficient lymphocytes and acetaminophen toxicity. Clin Pharmacol Ther 29:51–55.
  • Spraggs, C. F., Budde, L. R., Briley, L. P., Bing, N., Cox, C. J., King, K. S., et al. (2011). HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. J Clin Oncol 29:667–673.
  • Stewart, J. D., Horvath, R., Baruffini, E., Ferrero, I., Bulst, S., Watkins, P. B., et al. (2010). Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology 52:1791–1796.
  • St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., et al. (2006). Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127:397–408.
  • Strnad, P., Zhou, Q., Hanada, S., Lazzeroni, L. C., Zhong, B. H., So, P., et al.; Acute Liver Failure Study Group, Omary, M. B. (2010). Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations. Gastroenterology 39:828–835.
  • Sulkowski, M. S., Thomas, D. L., Mehta, S. H., Chaisson, R. E., Moore, R. D. (2002). Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 35:182–189.
  • Sun, Q., Zhu, R., Foss, F. W., Jr., Macdonald, T. L. (2008). In vitro metabolism of a model cyclopropylamine to reactive intermediate: insights into trovafloxacin-induced hepatotoxicity. Chem Res Toxicol 21:711–719.
  • Susin, S A., Zamzami, N., Kroemer, G. (1998). Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1366:151–165.
  • Sutton, A., Khoury, H., Prip-Buus, C., Cepanec, C., Pessayre, D., Degoul, F. (2003). The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 13:145–157.
  • Sutton, A., Nahon, P., Pessayre, D., Rufat, P., Poiré, A., Ziol, M., et al. (2006). Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis. Cancer Res 66:2844–2852.
  • Takahachi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T., Nagata, S. (1994). Human Fas ligand: gene structure, chromosomal location, and species specificity. Int Immunol 6:1567–1574.
  • Takakusa, H., Masumoto, H., Mitsuru, A., Okazaki, O., Sudo, K. (2008). Markers of electrophilic stress caused by chemically reactive metabolites in human hepatocytes. Drug Metab Dispos 36:816–823.
  • Tarantino, G., Conca, P., Basile, V., Gentile, A., Capone, D., Polichetti, G., et al. (2007). A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. Hepatol Res 37:410–415.
  • Teng, W. C., Oh, J. W., New, L. S., Wahlin, M. D., Nelson, S. D., Ho, H. K., et al. (2010). Mechanism-based inactivation of cytochrome P450 3A4 by lapatinib. Mol Pharmacol 78:693–703.
  • Thomson, A. W., Knolle, P. A. (2010). Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 10:753–766.
  • Thust, R., Tomicic, M., Klöcking, R., Voutilainen, N., Wutzler, P., Kaina, B. (2000). Comparison of the genotoxic and apoptosis-inducing properties of ganciclovir and penciclovir in Chinese hamster ovary cells transfected with the thymidine kinase gene of herpes simplex virus-1: implications for gene therapeutic approaches. Cancer Gene Ther 7:107–117.
  • Timbrell, J. A., Mitchell, J. R., Snodgrass, W. R., Nelson, S. D. (1980). Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo. J Pharmacol Exp Ther 213:364–369.
  • Tinel, M., Belghiti, J., Descatoire, V., Amouyal, G., Letteron, P., Geneve, J., et al. (1987). Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives. Biochem Pharmacol 36:951–955.
  • Tinel, M., Descatoire, V., Larrey, D., Loeper, J., Labbe, G., Letteron, P., et al. (1989). Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides. J Pharmacol Exp Ther 250:746–751.
  • Tinel, M., Berson, A., Vadrot, N., Descatoire, V., Grodet, A., Feldmann, G., et al. (2004). Subliminal Fas stimulation increases the hepatotoxicity of acetaminophen and bromobenzene in mice. Hepatology 39:655–666.
  • Trost, L. C., Lemasters, J. J. (1996). The mitochondrial permeability transition: a new pathophysiological mechanism for Reye′s syndrome and toxic liver injury. J Pharmacol Exp Ther 278:1000–1005.
  • Tsuboi, S. (1999). Expression of gamma-glutamylcysteine synthetase mRNA in regenerating rat liver. Biol Pharm Bull 22:1113–1115.
  • Tsuchishima, M., Tsutsumi, M., Shiroeda, H., Yano, H., Ueshima, Y., Shimanaka, K., et al. (2000). Study of mitochondrial DNA deletion in alcoholics. Alcohol Clin Exp Res 24:S12–S15
  • Tsutsumi, S., Gotoh, T., Tomisato, W., Mima, S., Hoshino, T., Hwang, H-J., et al. (2004). Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis. Cell Death Diff 11:1009–1016.
  • Tukov, F. F., Luyendyk, J. P., Ganey, P. E., Roth, R. A. (2007). The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury. Toxicol Sci 100:267–280.
  • Turk, B., Turk, V. (2009). Lysosomes as “suicide bags” in cell death: myth or reality? J Biol Chem 284:21783–21787.
  • Turnbull, D. M., Bone, A. J., Bartlett, K., Koundakjian, P. P., Sherratt, H. A. S. (1983). The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats. Biochem Pharmacol 32:1887–1892.
  • Turrens, J. F. (2003). Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344.
  • Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., Thurman, R. G. (2001). Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34:101–108.
  • Ulrich, R. G., Bacon, J. A., Brass, E. P., Cramer, C. T., Petrella, D. K., Sun, E. L. (2001). Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. Chem Biol Interact 134:251–270.
  • Ungo, J. R., Jones, D., Ashkin, D., Hollender, E. S., Bernstein, D., Albanese, A. P., et al. (1998). Antituberculous drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med 157:1871–1876.
  • Urano, F., Wang, X. Z., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., et al. (2000). Coupling of stress in the ER to activation of JNK protein kinases by transmembrane kinase IRE1. Science 287:664–666.
  • Vage, C., Svensson, C. K. (1994). Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P450 2C6/2C11 and 3A1. Drug Metab Dispos 22:572–577.
  • Vásquez-Vivar, J., Augusto, O. (1992). Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling. J Biol Chem 267:6848–6854.
  • Venhoff, A. C., Lebrecht, D., Reuss, F. U., Heckl-Ostreicher, B., Wehr, R., Walker, U. A., et al. (2009). Mitochondrial DNA depletion in rat liver induced by fosalvudine tidoxil, a novel nucleoside reverse transcriptase inhibitor prodrug. Antimicrob Agents Chemother 53:2748–2751.
  • Vergani, D., Mieli-Vergani, G., Alberti, A., Neuberger, J., Eddleston, A. L., Davis, M., et al. (1980). Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med 303:66–71.
  • Verrotti, A., Di Marco, G., la Torre, R., Pelliccia, P., Chiarelli, F. (2009a). Nonalcoholic fatty liver disease during valproate therapy. Eur J Pediatr 168:1391–1394.
  • Verrotti, A., la Torre, R., Trotta, D., Mohn, A, Chiarelli, F. (2009b). Valproate-induced insulin resistance and obesity in children. Horm Res 71:125–131.
  • Verrotti, A., Manco, R., Agostinelli, S., Coppola, G., Chiarelli, F. (2010). The metabolic syndrome in overweight epileptic patients treated with valproic acid. Epilepsia 51:268–273.
  • Victorino, R. M., Silveira, J. C., Baptista, A., de Moura, M. C. (1980). Jaundice associated with naproxen. Postgrad Med J 56:368–370.
  • Vispo, E., Moreno, A., Maida, I., Barreiro, P., Cuevas, A., Albertos, S., et al. (2010). Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings. AIDS 24:1171–1176.
  • von Schmiedeberg, S., Hanten, U., Goebel, C., Schuppe, H. C., Uetrecht, J., Gleichmann, E. (1996). T cells ignore the parent drug propylthiouracil but are sensitized to a reactive metabolite generated in vivo. Clin Immunol Immunopathol 80:162–170.
  • Vyas, P. M., Roychowdhury, S., Khan, F. D., Prisinzano, T. E., Lamba, J., Schuetz, E. G., et al. (2006). Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450. J Pharmacol Exp Ther 319:488–496.
  • Walker, U. A., Venhoff, N. (2005). Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity. Antivir Ther 10(Suppl 2):M117–M123.
  • Walker, U. A., Bäuerle, J., Laguno, M., Murillas, J., Mauss, S., Schmutz, G., et al. (2004). Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. Hepatology 39:311–317.
  • Walsh, J. S., Reese, M. J., Thurmond, L. M. (2002). The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes. Chem Biol Interact 142:135–154.
  • Wang, M., Dickinson, R. G. (1998). Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver. Drug Metab Dispos 26:98–104.
  • Watanabe, I., Tomita, A., Shimizu, M., Sugawara, M., Yasumo, H., Koishi, R., et al. (2003). A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus. Clin Pharmacol Ther 73:435–455.
  • Watkins, P. B., Zimmerman, H. J., Knapp, M. J., Gracon, S. I., Lewis, K. W. (1994). Hepatotoxic effects of tacrine administration in patients with Alzheimer′s disease. JAMA 271:992–998.
  • Watkins, P. B., Kaplowitz, N., Slattery, J. T., Colonese, C. R., Colucci, S. V., Stewart, P. W., et al. (2006). Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 296:87–93.
  • Watmough, N. J., Bindoff, L. A., Birch-Machin, M. A., Jackson, S., Bartlett, K., Ragan, C. I., et al. (1990). Impaired mitochondrial ß-oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria. J Clin Invest 85:177–184.
  • Weis, M., Kass, G. E., Orrenius, S., Moldéus, P. (1992). N-acetyl-p-benzoquinone imine induces Ca2+ release from mitochondria by stimulating pyridine nucleotide hydrolysis. J Biol Chem 267:804–809.
  • Weiss, C. F., Glazko, A. J., Weston, J. K. (1960). Chloramphenicol in the newborn infant. A physiologic explanation for its toxicity when given in excessive doses. N Engl J Med 262:787–794.
  • Wen, B., Moore, D. J. (2011). Bioactivation of glafenine by human liver microsomes and peroxidases: identification of electrophilic iminoquinone species and glutathione conjugates. Drug Metab Dispos May 31. [Epub ahead of print]
  • Wen, B., Zhou, M. (2009). Metabolic activation of the phenothiazine antipsychotics chlorpromazine and thioridazine to electrophilic iminoquinone species in human liver microsomes and recombinant P450s. Chem Biol Interact 181:220–226.
  • Wen, B., Ma, L., Zhu, M. (2008). Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s. Chem Biol Interact 173:59–67.
  • Wen, B., Chen, Y., Fitch, W. L. (2009). Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4. Drug Metab Dispos 37:1557–1562.
  • Werner, S., Kunz, S., Wolff, T., Schwarz, L. R. (1996). Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation. Cancer Res 56:4391–4397.
  • Wieckowski, M. R., Wojtczak, L. (1997). Involvement of the dicarboxylate carrier in the protonophoric action of long-chain fatty acids in mitochondria. Biochem Biophys Res Commun 232:414–417.
  • Wieland, P., Lauterburg, B. H. (1995). Oxidation of mitochondrial proteins and DNA following administration of ethanol. Biochem Biophys Res Commun 213:815–819.
  • Williams, D. P., O′Donnell, C. J., Maggs, J. L., Leeder, J. S., Uetrecht, J., Pirmohamed, M., et al. (2003). Bioactivation of clozapine by murine cardiac tissue in vivo and in vitro. Chem Res Toxicol 16:1359–1364.
  • Winnike, J. H., Li, Z., Wright, F. A., Macdonald, J. M., O′Connell, TM, Watkins, P. B. (2010). Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin Pharmacol Ther 88:45–51.
  • Wiseman, A., Attardi, G. (1978). Reversible tenfold reduction in mitochondria DNA content of human cells treated with ethidium bromide. Mol Gen Genet 167:51–63.
  • Wit, F. W., Weverling, G. J., Weel, J., Jurriaans, S., Lange, J. M. (2002). Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy. J Infect Dis 186:23–31.
  • Wolf, A., Weir, P., Segar, P., Stone, J., Shield, J. (2001). Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 357:606–607.
  • Wong, W. M., Wu, P. C., Yuen, M. F., Cheng, C. C., Yew, W. W., Wong, P. C., et al. (2000). Antituberculous drug-related liver dysfunction in chronic hepatitis B infection. Hepatology 31:201–206.
  • Woolf, T. F., Pool, W. F., Bjorge, S. M., Chang, T., Goel, O. P., Purchase, C. F. 2nd, et al. (1993). Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference. Drug Metab Dispos 21:874–882.
  • Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., et al. (1999). Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115–124.
  • Wu, J., Wong, W. W., Khosravi, F., Minden, M. D., Penn, L. Z. (2004). Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis. Cancer Res 64:6461–6468.
  • Yaghi, C., Honein, K., Boujaoude, J., Slim, R., Moucari, R., Sayegh, R. (2006). Influence of acetaminophen at therapeutic doses on surrogate markers of severity of acute viral hepatitis. Gastroenterol Clin Biol 30:763–768.
  • Yamamoto, N., Oliveira, M. B., Campello, Ade P., Lopes, L. C., Klüppel, M. L. (1988). Methotrexate: studies on the cellular metabolism. I. Effect on mitochondrial oxygen uptake and oxidative phosphorylation. Cell Biochem Funct 6:61–66.
  • Yamanaka, H., Gatanaga, H., Kosalaraksa, P., Matsuoka-Aizawa, S., Takahashi, T., Kimura, S., et al. (2007). Novel mutation of human DNA polymerase gamma associated with mitochondrial toxicity induced by anti-HIV treatment. J Infect Dis 195:1419–1425.
  • Yamauchi, K., Yamaguchi, N., Furukawa, T., Takatsu, K., Nakanishi, T., Ishida, K., et al. (2005). A murine model of acute liver injury induced by human monoclonal autoantibody. Hepatology 42:149–155.
  • Yan, C, Xin-Ming, Q, Li-Kun, G, Lin-Lin, L, Fang-Ping, C, Ying, X, et al. (2006). Tetrandrine-induced apoptosis in rat primary hepatocytes is initiated from mitochondria: caspases and endonuclease G (Endo G) pathway. Toxicology 218:1–12.
  • Yang, M., Chordia, M. D., Li, F., Huang, T., Linden, J., Macdonald, T. L. (2010). Neutrophil- and myeloperoxidase-mediated metabolism of reduced nimesulide: evidence for bioactivation. Chem Res Toxicol 23:1691–1700.
  • Yarchoan, R., Mitsuya, H., Myers, C. E., Broder, S. (1989). Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. N Engl J Med 321:726–738.
  • Yokota, I., Saijo, T., Vockley, J., Tanaka, K. (1992). Impaired tetramer assembly of variant medium-chain acyl-coenzyme A dehydrogenase with a glutamate or aspartate substitution for lysine 304 causing instability of the protein. J Biol Chem 267:26004–26010.
  • Yoshida, Y., Myozaki, M., Kuroda, E., Yamashita, U. (2001). Cytotoxic effect of an anti-liver monoclonal autoantibody obtained after neonatal thymectomy in mice. J Autoimmun 16:373–382.
  • Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., et al. (1987). Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A 84:9233–9237.
  • You, M., Fischer, M., Deeg, M. A., Crabb, D. W. (2002). Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 277:29342–29347.
  • You, Q., Cheng, L., Ju, C. (2010). Generation of T cell responses targeting the reactive metabolite of halothane in mice. Toxicol Lett 194:79–85.
  • Yourick, J. J., Faiman, M. D. (1991). Disulfiram metabolism as a requirement for the inhibition of rat liver mitochondrial low Km aldehyde dehydrogenase. Biochem Pharmacol 42:1361–1366.
  • Yu, H. Y., Wang, B. L., Zhao, J., Yao, X. M., Gu, Y., Li, Y. (2009). Protective effect of bicyclol on tetracycline-induced fatty liver in mice. Toxicology 261:112–118.
  • Yu, J., Brown, D. G., Burdette, D. (2010). In vitro metabolism studies of nomifensine monooxygenation pathways: metabolite identification, reaction phenotyping, and bioactivation mechanism. Drug Metab Dispos 38:1767–1778.
  • Yunis, A. A. (1989). Chloramphenicol toxicity: 25 years of research. Am J Med 87:N44–N48
  • Zhang, Z., Kolvraa, S., Zhou, Y., Kelly, D. P., Gregersen, N., Strauss, A. W. (1993). Three RFLPs defining a haplotype associated with the common mutation in human medium-chain acyl-CoA dehydrogenase (MCAD) deficiency occur in Alu repeats. Am J Hum Genet 52:1111–1121.
  • Zhang, Y., Bell, A., Perlman, P. S., Leibowitz, M. J. (2000). Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae. RNA 6:937–951.
  • Zhang, H., Barceló, J. M., Lee, B., Kohlhagen, G., Zimonjic, D. B., Popescu, N. C., et al. (2001). Human mitochondrial topoisomerase I. Proc Natl Acad Sci U S A 98:10608–10613.
  • Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., et al. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104–107.
  • Zhao, H., Cai, Y., Santi, S., Lafrenie, R., Lee, H. (2005). Chloroquine-mediated radiosensitization is due to the destabilization of the lysosomal membrane and subsequent induction of cell death by necrosis. Radiat Res 164:250–257.
  • Zhou, H., Gurley, E. C., Jarujaron, S., Ding, H., Fang, Y., Xu, Z., et al. (2006). HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes. Am J Physiol Gastrointest Liver Physiol 291:1071–1080.
  • Zimmerman, H. J. (1978) Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver. New York: Appleton-Century-Crofts.
  • Zimmerman, H. J. (1981). Effects of aspirin and acetaminophen on the liver. Arch Intern Med 141:333–342.
  • Zimmerman, H. J., Ishak, K. G. (1982). Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 2:591–597.
  • Zong, W. X., Li, C., Hatzivassiliou, G., Lindsten, T., Yu, Q. C., Yuan, J., et al. (2003). Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 162:59–69.
  • Zou, W., Beggs, K. M., Sparkenbaugh, E. M., Jones, A. D., Younis, H. S., Roth, R. A., et al. (2009). Sulindac metabolism and synergy with tumor necrosis factor-alpha in a drug-inflammation interaction model of idiosyncratic liver injury. J Pharmacol Exp Ther 331:114–121.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.